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ABSTRACT
DEVELOPMENT OF BICLUSTERING TECHNIQUES FOR GENE EXPRESSION
DATA MODELING AND MINING
JUAN XIE
2018
The next-generation sequencing technologies can generate large-scale biological
data with higher resolution, better accuracy, and lower technical variation than the arraybased counterparts. RNA sequencing (RNA-Seq) can generate genome-scale gene
expression data in biological samples at a given moment, facilitating a better
understanding of cell functions at genetic and cellular levels. The abundance of gene
expression datasets provides an opportunity to identify genes with similar expression
patterns across multiple conditions, i.e., co-expression gene modules (CEMs). Genomescale identification of CEMs can be modeled and solved by biclustering, a twodimensional data mining technique that allows clustering of rows and columns in a gene
expression matrix, simultaneously. Compared with traditional clustering that targets
global patterns, biclustering can predict local patterns. This unique feature makes
biclustering very useful when applied to big gene expression data since genes that
participate in a cellular process are only active in specific conditions, thus are usually coexpressed under a subset of all conditions.
The combination of biclustering and large-scale gene expression data holds
promising potential for condition-specific functional pathway/network analysis.
However, existing biclustering tools do not have satisfied performance on high-resolution
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RNA-Seq data, majorly due to the lack of (i) a consideration of high sparsity of RNA-Seq
data, especially for scRNA-Seq data, and (ii) an understanding of the underlying
transcriptional regulation signals of the observed gene expression values. QUBIC2, a
novel biclustering algorithm, is designed for large-scale bulk RNA-Seq and single-cell
RNA-seq (scRNA-Seq) data analysis. Critical novelties of the algorithm include (i) used
a truncated model to handle the unreliable quantification of genes with low or moderate
expression; (ii) adopted the Gaussian mixture distribution and an information-divergency
objective function to capture shared transcriptional regulation signals among a set of
genes; (iii) utilized a Dual strategy to expand the core biclusters, aiming to save dropouts
from the background; and (iv) developed a statistical framework to evaluate the
significances of all the identified biclusters. Method validation on comprehensive data
sets suggests that QUBIC2 had superior performance in functional modules detection and
cell type classification. The applications of temporal and spatial data demonstrated that
QUBIC2 could derive meaningful biological information from scRNA-Seq data.
Also presented in this dissertation is QUBICR. This R package is characterized
by an 82% average improved efficiency compared to the source C code of QUBIC. It
provides a set of comprehensive functions to facilitate biclustering-based biological
studies, including the discretization of expression data, query-based biclustering, bicluster
expanding, biclusters comparison, heatmap visualization of any identified biclusters, and
co-expression networks elucidation.
In the end, a systematical summary is provided regarding the primary applications
of biclustering for biological data and more advanced applications for biomedical data. It

xiii
will assist researchers to effectively analyze their big data and generate valuable
biological knowledge and novel insights with higher efficiency.
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CHAPTER 1: Introduction
1.1 Gene Expression Data
Gene expression is the process by which information from a gene is used in the
synthesis of a functional product, that is, a molecule needed to perform a job in the cell
(e.g., protein). The process mainly consists of two steps: transcription and translation. In
transcription, the DNA sequence of a gene is copied to make an RNA molecule. In
translation, the sequence of the mRNA is decoded to specify the amino acid sequence of
a polypeptide. Since genes encode proteins and proteins dictate cell functions, the genes
expressed in a cell determine what the cell can do.
Many biotechnologies are available to profile gene expression. Microarrays
emerged in the late 1990s, which is the first high-throughput technology that enables the
researchers to monitor the expression level of tens of thousands of genes simultaneously
[1]. Microarrays are typically microscope slides that are printed with thousands of tiny
spots in ordered positions, with each spot containing a known DNA sequence or gene.
After steps of mRNA extraction, cDNA synthesis, cDNA fragmentation, and fluorescent
labeling, the relative abundance of genes is quantified by detecting fluorescent intensity,
which is continuous and positive. Due to its easy accessibility and low cost, microarrays
have been the most widely used platforms in generating gene expression. However,
microarrays need a reference genome and transcriptome to be available; thus, their
application is confined to organisms whose genome have already been sequenced.
With the advent of massively parallel sequencing, next-generation sequencing
(NGS) technologies have become more affordable. Compared to the array-based
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counterparts, NGS has higher resolution, better accuracy, lower technical variation and
many other advantages [2, 3]. It allows for a much faster-paced accumulation of largescale biological data. The high-throughput RNA-sequencing (RNA-Seq) is a
revolutionary technology for gene expression profiling and promises a comprehensive
picture of the transcriptome for a biological process [4, 5]. Unlike microarrays, RNA-Seq
can be used to new organisms whose genome has not been sequenced yet. It extracts
usable information from the mature mRNA within a biological source and generates a
massive number of short segments (reads, 100-250 bps), which enable the discrete
quantification of all genes expressed in a cell [5, 6]. Currently, researchers can either
analyze a large sample of cells from a single organism in the form of bulk RNA-Seq data
or isolate individual cells from complex organisms and measure their transactional
activity through single-cell RNA-sequencing (scRNA-Seq). Such gene expression data
from individual cells promises to provide a better understanding of cell functions at
genetic and cellular levels[7] . In short, these biotechnologies have generated large
genome-scale gene expression data in the public domain, and their tremendous values
have been confirmed in many research areas such as elucidation of cell-type-specific
regulatory networks [8, 9] and cancer & complex diseases studies [10-12].
1.2 Biclustering Techniques
The abundance of gene expression datasets provides an opportunity to identify
genes with similar expression patterns across multiple conditions, i.e., co-expression gene
modules (CEMs). The genes in these modules tend to be functionally related or coregulated by the same transcriptional regulatory signals (TRSs). Thus, they enable the
higher-level interpretation of gene expression data, improve functional annotation,
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facilitate inference of gene regulatory mechanisms, and are useful for a better
understanding of disease/cancer mechanisms. Genome-scale identification of CEMs can
be modeled and solved by biclustering [13], which was introduced by Hartigan in 1972
[14] and applied to gene expression data analysis by Cheng and Church in 2000 [15].
Biclustering is a two-dimensional data mining technique that allows clustering of rows
(representing genes) and columns (representing samples/conditions) in a gene expression
matrix, simultaneously. The biclustering method can capture biologically meaningful and
computationally significant CEMs, by identifying (possibly overlapped) homogeneous
submatrices, subsets of rows with a coherent pattern across subsets of columns that satisfy
specific quality metrics (e.g., mean squared residue used in [15] and MSE used in [16]).
This unique feature makes it very useful when applied to big gene expression data since
genes that participate in a cellular process are only active in specific conditions, thus are
usually co-expressed under a subset of all conditions.
Besides the identification of CEMs, scRNA-Seq data enables studies of individual
cells or cell types as well as their complex interactions under specific stimuli, e.g., cell
types classification and clustering. In multicellular organisms, biological function emerges
when various cell types form complex organs [17]. Investigations into organ development,
cell function, and disease mechanisms highly depend upon accurate identification and
categorization of cell types, sometimes along with their temporal and spatial features [18].
Traditionally, cell type was defined based on morphological properties or marker proteins,
yet this method failed to characterize the full diversity of cells. scRNA-Seq data provides
the possibility to group cells based on their genome-wide transcriptome profiles, and
several studies have already been carried out using scRNA-Seq data to identify novel cell
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types, proving its power to unravel the full diversity of cells in human and mouse [8].
Mathematically, the problem of cell types classification can be treated as biclustering
problems, as the essence is to find sub-populations of cells sharing common expression
patterns among subsets of genes.
A substantial number of biclustering methods were developed during the past 18
years [15, 16, 19-36]. SAMBA [28], ISA [29], Bimax [30], QUBIC [31], and FABIA [37]
are some popular algorithms for general purpose. CCC-biclustering [38-40] is designed for
temporal data analysis, and BicPAM [41], BicNET [35, 42] and MCbiclust [43] are three
recent studies. Besides, several tools (R packages, web servers, etc.) have been developed
to facilitate users with a limited computational background [23, 44-50]. GEMS [47] is a
web server for gene expression mining based on a Gibbs sampling paradigm; and biclust
[48] and QUBICR [49] are two R packages integrating multiple existing algorithms, data
preprocessing functions, and interpretation & visualization of the results. A list of some
highly cited or recently published biclustering algorithms and tools is shown in Table1.
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Table 1. Summary of biclustering algorithms and tools, sorted in the decreasing order of their numbers of citation since published.
Application or usage was noted for some of the algorithms. Citations were collected via Google Scholar as of Sep 2018

Algorithms/

Citations*

Tools

Published

Review comments*

Notes

Year

SAMBA [28]

939

2002

-

-

Bimax[30]

874

2006

E

Choice for constant-upregulated biclusters

-

ISA [29]

414

2002

E

Choice for constant-upregulated biclusters;

-

NC

Plaid[16]

717

2002

E

Spectral[51]

654

2003

NC

cMonkey[52] /

257/

2006/

-

cMonkey2 [53]

21

2015

FABIA [32]

198

2010

Choice for constant-upregulated biclusters;
Has the highest enriched bicluster ratio in
real datasets
Performs well on human and synthetic
data

E

Integrates various orthogonal pieces
of information which support
evidence of gene co-regulation, and
optimizes biclusters to be supported
simultaneously by one or more of
these prior constraints
Choice for constant-upregulated biclusters;

NC

SSVD [54]

192

2010

Performs well on synthetic data

-

-

Performs well on synthetic data
-
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QUBIC [31]

167

2009

E

Choice for constant-upregulated
biclusters; Has the highest enriched
bicluster ratio in real datasets
NC

Performs well on synthetic and human
data
BBC[55]

126

2008

E

CPB[56]

40

2009

E

LAS [57]

113

2009

-

Best one for plaid biclusters

-

Best one for constant, scale, shift and
shift-scale datasets
Discovery of biologically relevant
structures in high dimensional data;
Significant results highlighted with
a large negative average image for
easy observation.

BackSPIN [58]

830

2015

-

First biclustering algorithm for
scRNA-Seq data

PPA [59]

93

2008

-

-

CCC-Biclustering [60]

95

2010

-

Coherent biclusters with maximal
contiguous columns in linear time;
Combining time-series expression
with the regulatory network.

COALESCE [61]

80

2009

E

BioNMF [62]

79

2006

-

-

BiGGEsTs [39]

51

2009

-

Suitable for temporal biclustering

Choice for constant-upregulated biclusters

Efficient enough to discover
expression biclusters and putative
regulatory motifs in metazoan
genomes and very large microarray
compendia (>10,000 conditions)
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NCIS [63]

44

2014

-

Identification of cancer subtypes

FD-MSCM [64]

35

2010

-

-

BicPAM [41]

28

2014

-

Biclustering for biomedical data
analysis;
Suitable for non-constant biclusters

IBBiG [65]

24

2012

-

-

BUBBLE [66]

14

2006

-

Based on bottom-up search strategy;
Using mean squared residue
measurement.

SparseBC [67]

21

2014

-

-

BicNET [35]

13

2016

-

Discovery of non-trivial modules
directly for biological network
construction;
Noisy and missing interaction fix;
Analysis of protein interaction and
gene interaction networks

MCbiclust [68]

3

2017

-

-

Note: In the Reviewer Comments column, algorithms/tools mentioned by [69] are denoted by ‘E’, mentioned by [70] are denoted by ‘NC’
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Several review studies of biclustering have been carried out in different
perspectives [30, 71-75]. For example, Pontes et al. presented a taxonomy of 47
biclustering algorithms according to their search strategies [76], and Busygin et al.
emphasized the mathematical models and concepts in biclustering techniques [77]. Padilha
et al. claimed that an algorithm only achieved satisfactory results in a specific context and
the best choice depends on particular objectives [74]. Eren et al. compared 12 popular
algorithms and concluded that QUBIC is one of the best as it achieves the highest
performance in synthetic datasets and captures a high proportion of enriched biclusters on
real datasets, and Plaid, FABIA, ISA and Bimax are the recommended tools for capturing
upregulated biclusters [78]. Adetayo et al. presented an overview of data analysis using
biclustering methods from a practical point of view, accompanied by R examples [79]. In
2018, Saelens et al. ranked Spectral, ISA, FABIA and QUBIC as the top biclustering
methods regarding predicting gene modules from human and/or synthetic data [70].
1.3 QUBIC
QUBIC (Qualitative BIClustering algorithm) is a qualitative biclustering
algorithm, which was first introduced in 2009. It assumes that a gene has three
expression states under all the conditions, i.e., highly-expressed, lowly-expressed, and
normally-expressed. The values in the first two expression states are so-called affected
values. QUBIC employs a framework to identify dynamic cutoffs and corresponding
affected values for different genes (Figure 1). A discretized qualitative matrix (MR) can
be generated after applying the above process to each gene, with non-zero integers
representing affected values and 0s being background. Then a weighted graph is
constructed based on this matrix, where each node corresponds to a gene, and each edge
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has a weight indicating the similarity level between the two corresponding genes. The
aim is to search biclusters corresponding to induced heavy subgraphs, which is an NPhard problem. QUBIC heuristically iterates a seed list (S), where a seed represents a pair
of genes, and its weight is the number of conditions under which they have the same
values in MR. In each iteration, it starts from a feasible seed with the highest weight, then
expands vertically and horizontally to recruit more genes and conditions. Finally, QUBIC
outputs a bicluster with max (min (I, J)), where I and J being the number of rows and
columns of the bicluster (Figure 1).
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Figure 1. Workflow of QUBIC. QUBIC sorts the expression values of the gene i under all given
conditions in an increasing order: 𝑣𝑖1 ⋯ 𝑣𝑖,𝑠−1 𝑣𝑖𝑠 ⋯ 𝑣𝑖,𝑐−1 𝑣𝑖𝑐 𝑣𝑖,𝑐+1 ⋯ 𝑣𝑖,𝑚−𝑠+1 𝑣𝑖,𝑚−𝑠+2 ⋯ 𝑣𝑖𝑚 ,
where c=m/2 and s-1= m×q (q=6% by default). Then it selects initial bounds L= 𝑣𝑖,𝑠−1 and U=
𝑣𝑖,𝑚−𝑠+1 . QUBIC adjusts the bounds based on their distance from the median (M= 𝑣𝑖𝑐 ), e.g., if
(U-M) > (M-L), then use U’ = (M-L) + M = 2M –L as the new upper bound. The values less or
equal to L are labeled as -1, those greater or equal to U’ are labeled as 1, and those fall between L
and U’ are labeled as 0. Repeat this process for each gene in the dataset, a representing matrix MR
can be generated.

1.4 Qserver
QUBIC has been proved to be able to solve more general biclustering problems
than previous biclustering algorithms[31]. To fully utilize the analysis power of QUBIC,
a web server named Qserver (Qualitative BIClustering server) was developed in
2011[23]. Qserver integrates capabilities of biclustering with cis-regulatory motifs
prediction and functional enrichment analyses. Specifically, Qserver provides the
following functionalities: (i) biclustering analysis using QUBIC; (ii) prediction and
assessment of conserved cis-regulatory motifs in promoter sequences of the predicted coexpressed genes; (iii) functional enrichment analyses of the predicted co-expressed gene
clusters using Gene Ontology (GO) terms, and (iv) visualization capabilities in support of
interactive biclustering analyses.
For biclustering analysis, QUBIC algorithm is implemented. Users can provide
continuous or discretized gene expression matrix as input. If continuous data is provided,
Qserver will automatically discretize it qualitatively. Qserver allows users to adjust the
main parameters in QUBIC, and suggestion regarding how to change for different
applications is provided in the Help page.
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After obtaining sets of biclusters, QServer allows computationally validating of
the biclusters by predicting conserved cis-regulatory motifs among the promoter
sequences automatically extracted from the upstream sequences (the default value is 300
bps long) of the co-expressed genes. Two motif prediction programs, BOBRO [80] and
MEME[81] are provided, both of which attempt to find conserved sequences among a
set of given promoter sequences using different strategies, and both offer a statistical
significance score for each predicted motif.
For the predicted biclusters, Qserver can also conduct functional enrichment
analysis based on GO classification. Specifically, given a bicluster, Qserver will check if
it is enriched with a GO term, compared against the background gene distribution, i.e.,
the whole genome. A P-value and enrichment ratio of that GO term will be provided.
It is common that different sets of gene expression data may use different naming
conventions for genes. To deal with this issue, Qserver collected three gene/protein
naming systems (i.e., GI, locus, and RefSeq) so that it can automatically detect the
naming system used in an expression matrix. It also collected the genome sequences and
the gene annotations from the NCBI Genome database in support of motif prediction and
functional enrichment analysis, covering human, mouse, Arabidopsis, B subtilis,
Synechocystis sp. PCC6803, Synechococcus sp. WH8102 and E. coli K12. For other
organisms, Qserver will only do biclustering analysis and plot the heatmaps for
biclusters.
In summary, Qserver provides three functional modules for the expression data.
First, the input matrix is subject to biclustering analysis using QUBIC. For each
bicluster, cis-regulatory motifs are then identified in the promoter regions of its
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component genes, using either MEME or BOBRO. Qserver will also provide the detailed
information of each identified motif, including its P-value and the logo plot. The third
module is to identify enriched GO categories among genes in each bicluster. The
workflow of Qserver is shown in Figure 2.

Figure 2. An example workflow of using Qserver.
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CHAPTER 2: QUBIC2—A Novel Biclustering Algorithm for Large-scale RNA-Seq
Data Analysis
Although numerous algorithms and tools have been developed for gene
expression data analysis, most existing biclustering algorithms are designed and
evaluated using microarray rather than RNA-Seq data. One of the unique features of gene
expression data derived from RNA-Seq, especially the scRNA-Seq data, is the massive
zeros (up to 60% of all the genes in a cell have read counts being zeros) [82, 83]. The
normalized read counts roughly follow lognormal distributions; however, the raw zero
counts of specific genes will lead to negative infinity after logarithmic transformation
[84-87], resulting in unquantifiable errors. Therefore, the biclustering methods that are
successful for microarray cannot be directly applicable to RNA-Seq data [88], and novel
methods taking full consideration of characteristics of RNA-Seq data are urgently needed
in the public domain. In this chapter, I will present QUBIC2, a novel biclustering
algorithm developed for large-scale RNA-Seq data analysis.
2.1 Overall Design of QUBIC2
Inheriting the qualitative representation and graph-theory based model from
QUBIC [31], QUBIC2 has four unique features: (i) developed a rigorous truncated model
to handle the unquantifiable errors caused by zeros, and used a reliable qualitative
representation of gene expression to reflect expression states corresponding to various
TRSs; (ii) integrated an information-divergence objective function in the biclustering
framework in support of functional gene modules identification; (iii) employed a Dual
strategy to expand the cores, aiming to save dropouts from the background.; and (iv)
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developed a robust P-value framework to support statistical evaluation of all the
identified biclusters. Details of these four features are showcased as follows.
A mixture of left-truncated Gaussian distributions (LTMG) model was designed to
fit the RNA-Seq data, rather than discarding zeros or adding a small constant to original
counts [85, 89]. The basic idea is to treat the large number of observed zeros and low
expressions as left censored data in the mixture Gaussian model of each gene [90, 91],
assuming that the observed frequency of expressions on the left of the censoring point
should be equal to the area of the cumulative distribution function of the mixture Gaussian
distribution left of the censoring point. Furthermore, we assumed that a gene should receive
𝐾 possible TRSs under all the conditions, and its expression profile would follow a mixture
of 𝐾 left truncated Gaussian distributions. The LTMG model was applied to fit the
expression value of each gene, and the gene expression value under a specific condition
was labeled to the most likely distribution. Accordingly, a row consisting of discrete values
(1,2, ⋯, 𝐾) for each gene was generated (Figure 3A). Then this qualitative row was split
into 𝐾 new rows, such that in the 𝑖th row those previously labeled as 𝑖 are labeled as 1,
while the rest were labeled as 0. Finally, a binary representing matrix MR was generated.
A weighted graph 𝐺 = (𝑉, 𝐸) was constructed based on MR, where nodes 𝑉
correspond to genes, edges 𝐸 connecting every pair of genes (Figure 3B). The edge weight
indicates the similarity between the two corresponding genes, which is defined as the
number of conditions in which the two genes have 1s in MR. Intuitively, two genes from a
bicluster should have a heavy edge in 𝐺 innately while two random genes may have a
heavy edge only accidentally. Hence, a bicluster should correspond to a maximal subgraph
of 𝐺, with edges typically heavier than the edges of an arbitrary subgraph. Identifying all
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the biclusters equals to identifying all the heavy subgraphs in 𝐺, which is an NP-hard
problem. Therefore, a heuristic strategy was designed as follows.
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Figure 3. QUBIC2 workflow. A. Discretization of gene expression data. Each gene’s expression
profile is fitted by the LTMG model and discretized qualitatively. Finally, a binary representing
matrix is generated; B. Graph construction and seed selection. A weighted group is constructed
based on the representing matrix. Then a feasible seed is selected from the seed list; C. Build an
initial core based on the seed. QUBIC2 will recruit genes with higher weight with the seed. If two
genes have the same weight, the one with higher KL score will be selected; D. Expand core and
determine pool. QUBIC2 will expand the core vertically and horizontally to recruit more genes
and conditions, respectively. The intersected zone created by extended genes and conditions as a
Dual searching pool; E. Dual search in the pool and output the bicluster with genes and
conditions that come from Core and Dual as final bicluster (red box); F. Statistical evaluation of
identified biclusters based on either biological annotations or the size of the bicluster.
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The algorithm would iterate a seed list (𝑆), which is the sorted list of edges in 𝐺 in
the decreasing order of their weights (i.e., 𝑤(𝑒1 ) ≥ 𝑤(𝑒2 ) ≥ ⋯ , 𝑤(𝑒 𝐸 ) ). An edge 𝑒𝑖 =
𝑖

is selected as a seed if and only if at least one of

identified biclusters, or

𝑖

and

𝑖

and

is not in any previously

are in two nonintersecting biclusters in terms of genes.

QUBIC2 first built a core bicluster from a seed and then expanded to recruit more genes
and conditions into a to-be-identified bicluster, until the Kullback-Leibler divergence score
(KL score) was locally optimized. It was proposed based on the assumption that the
difference between a bicluster and its background should be larger than the difference
between an arbitrary same-size submatrix and its background. The KL score of a bicluster
was designed to quantify this difference as the larger of the difference was, the larger of
the score is (Figure 3C. See Section 2.2.2 for details).
The previous steps predict an all-1 core. We believe that some 0s outside the cores
are dropouts and therefore we need to expand the cores. Since it is difficult to determine
the cutoffs for expansion, we first expand the core both horizontally and vertically, and
then heuristically search another core in the expanded region. Specifically, during
expansion, the algorithm will control the consistency level for a bicluster, which is defined
as the minimum ratio of the number of 1s in a column/row and the number of rows/columns
in the bicluster. Then QUBIC2 will adopt the same strategy as it used for predicting Cores
to search another core in the expanded region (Figure 3D-E), giving rise to a submatrix (I,
J) of MR (i.e., a bicluster) with optimized consistency level and maximal KL score can be
identified. It is assumed that 0s induced in this way are more likely to be dropouts.
Furthermore, for the first time, a statistical framework based on the size of the
biclusters was implemented to calculate a P-value for each of the identified biclusters. The
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problem of assessing the significance of identified biclusters was formulated as calculating
the probability of finding at least one submatrix enriched by 1 from a binary matrix with
given size, with a beta distribution employed during the process. This P-value framework
enables users systematically evaluate the statistical significance of all the identified
biclusters, especially for those from less-annotated organisms (Figure 3F).
2.2 Detailed Methods in QUBIC2
2.2.1 Left Truncated Mixed Gaussian (LTMG) Model and Qualitative Representation
To accurately model the gene expression profile of RNA-Seq and scRNA-Seq
data, we explicitly developed a mixed Gaussian model with left truncation assumption.
Denotes the log-transformed FPKM, RPKM or CPM expression values of gene X over 𝑁
conditions as X = {𝑥1 , 𝑥 }, we assumed that 𝑥  𝑋 follows a mixture of 𝑘 Gaussian
distributions, corresponding to 𝑘 possible TRSs. The density function of 𝑥 is:

𝑝 𝑥 ; Θ = ∑ 𝛼𝑖 𝑝(𝑥 ; 𝜃𝑖 ) = ∑ 𝛼𝑖
𝑖=1

𝑖=1

1
√2𝜋𝜎𝑖

− 𝑥𝑗 −𝜇𝑖
𝑒 2𝜎𝑖2

2

And the density function of X is:
𝑝(X; Θ) = ∏ 𝑝(𝑥 ; Θ) = ∏ ∑ 𝛼𝑖 𝑝(𝑥 ; 𝜃𝑖 ) = ∏ ∑ 𝛼𝑖
=1

=1 𝑖=1

=1 𝑖=1

1
√2𝜋𝜎𝑖

− 𝑥𝑗 −𝜇𝑖
𝑒 2𝜎𝑖2

2

= 𝐿(Θ; 𝑋)

where 𝛼𝑖 is the mixing weight, 𝜇𝑖 and 𝜎𝑖 are the mean and standard deviation of ith
Gaussian distribution, which can be estimated by the EM algorithm with given X:
Θ∗ =

arg max 𝐿(Θ;𝑋)
Θ

To model the errors at zero and the low expression values, we introduce a
parameter 𝑍𝑐𝑢𝑡 for each gene expression profile and consider the expression values
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smaller than 𝑍𝑐𝑢𝑡 as left censored data. With the left truncation assumption, the gene
expression profile is split into 𝑀 truly measured expression value (> 𝑍𝑐𝑢𝑡 ) and 𝑁 − 𝑀
left censored gene expressions (≤𝑍𝑐𝑢𝑡 ) for the 𝑁 conditions. Latent variables 𝑦 and 𝑍
are introduced to estimate Θ by the following Q function:
𝑚
𝑡−1 )

𝑄(Θ; Θ

= ∑ 𝑝 𝑦 |𝑥 ; 𝛩

𝑡−1

∑ ∑ log(𝛼𝑖 𝑝(𝑥 ; 𝜇𝑖 , 𝜎𝑖 ))
=1 𝑖=1

+ ∑ 𝑝 𝑦 |𝑧 ; 𝛩𝑡−1

∑ ∑ log(𝛼𝑖 𝑝(𝑧 ; 𝜇𝑖 , 𝜎𝑖 ))
=𝑚+1 𝑖=1

To estimate the parameters Θ that maximizes the likelihood function, we have
Maximization step of the EM algorithm as [92]:
𝑎𝑖𝑡

𝑢𝑖𝑡 =

𝑀

𝑁

=1

=𝑀+1

1
= (∑ 𝑃 𝑖|𝑥 , Θ𝑡−1 + ∑ 𝑃(𝑖 𝑍 , 𝑍𝑐𝑢𝑡 , Θ𝑡−1 ))
𝑁

𝑍 − 𝑢𝑖𝑡−1
∑𝑀=1 𝑥 𝑃 𝑖|𝑥 , Θ𝑡−1 + ∑𝑁=𝑀+1(𝑢𝑖𝑡−1 − 𝜎𝑖𝑡−1 𝐻( 𝑐𝑢𝑡
))𝑃(𝑖 𝑍 , 𝑍𝑐𝑢𝑡 , Θ𝑡−1 )
𝜎
𝑖

∑𝑀=1 𝑃(𝑖 𝑥 , Θ𝑡−1 ) + ∑𝑁=𝑀+1 𝑃(𝑖 𝑍 , 𝑍𝑐𝑢𝑡 , Θ𝑡−1 )
𝜎𝑖𝑡

2

𝑍𝑐𝑢𝑡 − 𝑢𝑖𝑡−1
𝑍 − 𝑢𝑖𝑡−1
∗ 𝐻( 𝑐𝑢𝑡
)) ∗ 𝑃(𝑖 𝑍 , 𝑍𝑐𝑢𝑡 , Θ𝑡−1 )
𝜎𝑖
𝜎𝑖
∑𝑀=1 𝑃(𝑖 𝑥 , Θ𝑡−1 ) + ∑𝑁=𝑀+1 𝑃(𝑖 𝑍 , 𝑍𝑐𝑢𝑡 , Θ𝑡−1 )
2

=

∑𝑀=1 𝑃 𝑖|𝑥 , Θ𝑡−1 (𝑥 − 𝑢𝑖𝑡−1 )2 + 𝜎𝑖𝑡−1 ∑𝑁=𝑀+1(1 −

𝑃(−∞<𝑍𝑗 <𝑍𝑐𝑢𝑡 𝑢𝑖𝑡−1 ,𝜎𝑖𝑡−1 )

where 𝑃 𝑖|𝑍 , 𝑍𝑐𝑢𝑡 , Θ𝑡−1 = ∑𝐾

𝜙(𝑥)

, 𝐻(𝑥) = Φ(𝑥), 𝜙(𝑥) and Φ(𝑥) are

𝑡−1 ,𝜎 𝑡−1 )
𝑖=1 𝑃(−∞<𝑍𝑗 <𝑍𝑐𝑢𝑡 𝑢𝑖
𝑖

the pdf and cdf of standard normal distribution.
Parameters Θ can be estimated by iteratively running the estimation (E) and
maximization (M) steps. In this study, 𝑍𝑐𝑢𝑡 is set for each gene as the logarithm of the
minimal non-zero RPKM/FPKM/TPM value in the gene’s expression profile. The EM
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algorithm is conducted for 𝐾 = 1, …, 9 to fit the expression profile of each gene and the 𝐾
that gives the best fit is selected according to the Bayesian Information Criterion (BIC):
𝐵𝐼𝐶 = −2 ln(Θ∗ ) + 3𝐾ln(𝑁)

where 𝐾 is the number of TRS, 𝐾 is the number of conditions. 𝐾 that minimizes the BIC
will be selected.
Then the original gene expression values will be labeled to the most likely
distribution under each condition. In detail, the probability that 𝑥 belongs to distribution 𝑖
is formulated by:
−(𝑥𝑗 −𝜇𝑖 )2
2
𝑒 2𝜎𝑖

𝛼𝑖

𝑝 𝑥 ∈ 𝑇𝑅𝑆 𝑖|𝐾, Θ∗ ∝

√2𝜋𝜎 2

And

𝑥

is

labeled

by

TRS

𝑖

if

𝑝 𝑥 ∈ 𝑇𝑅𝑆 𝑖|𝐾, Θ∗ =

max (𝑝 𝑥 ∈ 𝑇𝑅𝑆 𝑖|𝐾, 𝛩 ∗ ). In such a way, a row consisting of discrete values (1,2,

𝑖=1,⋯,𝐾

, 𝐾) for each gene will be generated.
2.2.2 KL Score
A Kullback-Leibler divergence score (KL score) is introduced in QUBIC 2 to guide
candidate-selection and biclustering optimization. The KL score of a bicluster is defined
as:
𝐾𝐿𝐵 =

𝑁
1
∑ ∑
𝑁
=1
𝑖∈{

,1}

𝑅(𝑖, 𝑗) × 𝑙𝑜

𝑀
𝑅(𝑖, 𝑗) 1
+ ∑
∑
𝑄(𝑖, 𝑗) 𝑀
=1
𝑖∈{

,1}

𝐶(𝑖, 𝑘) × 𝑙𝑜

𝐶(𝑖, 𝑘)
𝑃(𝑖, 𝑘)

where 𝑁 and 𝑀 are the numbers of rows and columns of a submatrix B in MR, respectively.
𝑅(𝑖, 𝑗) represents the proportion of element 𝑖 in row 𝑗 of B, 𝑄(𝑖, 𝑗) is the proportion of 𝑖 in
the entire corresponding row, 𝐶(𝑖, 𝑘) is the proportion of 𝑖 in column 𝑘 of B, and 𝑃(𝑖, 𝑘) is
the proportion of 𝑖 in the entire corresponding column.
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Meanwhile, the KL score for a gene quantify the similarity between a candidate
gene 𝑗 and a bicluster, which is defined as follows:
𝐾𝐿 = ∑

𝑖∈{ ,1}

𝑅(𝑖, 𝑗) × 𝑙𝑜

𝑅(𝑖, 𝑗)
𝑄(𝑖, 𝑗)

where 𝑅(𝑖, 𝑗) represent the proportion of 𝑖 under corresponding columns of the current
bicluster.
2.2.3 QUBIC2 Algorithm
The QUBIC2 algorithm concludes as follows:
Step 1 (Data discretization and qualitative representation): Given an expression
matrix with log-transformed FPKM, RPKM or CPM value for genes, use LTMG model to
fit data. Label the values to the most likely distribution to get a representing row for each
gene. Split these rows into multiple rows to get the representative matrix MR (Figure 3A).
Step 2 (Graph construction and seed selection): Construct a weighted graph for
MR. Select a feasible seed from the seed list; Stop if the seed list is empty (Figure 3B).
Step 3 (Build core bicluster): Build an initial bicluster by finding all the conditions
under which the two genes of the seed have 1s in MR. Set these columns of the two genes
as the current bicluster B = (I, J). Expand B by adding a new gene that has the most 1s in
J, giving rise to a new bicluster B’ = (I’, J’), where I’ is I after adding the new gene and J’
is J by deleting those columns with 0s. If two genes have the same number of 1s in J,
choose the one with larger KL similarity with B (Figure 3C). If KLB’ > KLB, set B to B’
and repeat Step 2, otherwise stop and denote B as Core. Go to Step 4.
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Step 4 (Core expansion): Expand the Core horizontally and vertically under preset
consistency level as follows: for each gene(row) i not in B, if the ratio between the number
of 1s in row i under J and |J| is ≥c, mark it as an extended gene; for each condition (column)
j not in B, if the ratio between the number of 1s in the column j among I and |I| is ≥c, mark
it as an extended condition. (Figure 3D). Mark the intersected zone created by extended
genes and conditions as a Dual searching pool (brown box in Figure 3D). Go to Step 5.
Step 5 (Search Dual): Search Dual in the intersected expanded zone, using the
same process in Step 3, output the bicluster with genes and conditions that come from Core
and Dual (red box in Figure 3E). Delete current seed, go to step 1.
2.2.4 Size-based P-value
For well-annotated organisms, the P-value of an identified bicluster enriching
with a specific regulatory pathway can be calculated based on a hypergeometric
distribution. However, the known experimental annotation is currently limited, even for
most well-studied model organisms (about half of the protein-coding genes of E. coli
have solid experimental evidence for their function in KEGG and GO) [93]. This status
still limits the capability of a systematic evaluation of all the identified biclusters. To fill
this gap, we calculate an alternative size-based P-value as follows. For a binary
representing matrix MR, containing 𝑚 rows and 𝑛 columns, suppose we obtain an 𝑚1 by-𝑛1 bicluster M1 with all the elements be 1s. The probability of 𝑛1 ≥ 𝑊 can be assessed
by the following formula [94], giving rise to a P-value of the bicluster M1:
𝑃(𝑛1 ≥ 𝑊) = lim 𝑛
→∞

where 𝛼 =

𝑚0
0

,𝛽 =

𝑚1
1

1

−(𝛽+1) 𝑊−𝑠( 1 , 0 ,𝛽)

(log 𝑏 𝑛 )𝛽+1

, 𝑏 = 𝑝, 𝑝 = 𝑃 𝑀𝑖, = 1 = 1 − 𝑃 𝑀𝑖, = 0 for ∀𝑖, 𝑗
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𝑠(𝑛1 , 𝑛 , 𝛽) =

𝛽+1
𝛽+1
𝛽+1
log 𝑏 𝑛 −
log 𝑏
log 𝑏 𝑛
𝛽
𝛽
𝛽
+

+ log 𝑏 𝛼

(1 + 𝛽) log 𝑏 𝑒 − 𝛽 log 𝑏 𝛽
𝛽

2.3 Functional Gene Modules Detection from RNA-Seq Data
2.3.1 Data Acquisition
A total of four expression datasets were used in this section, that is, one synthetic
RNA-Seq data (22,846 rows × 100 columns), one bulk RNA-Seq dataset from
Escherichia coli (E. coli, 4,497 rows × 155 columns), a bulk RNA-Seq dataset from
TCGA (3,084 rows × 8,555 columns), and a scRNA-Seq dataset from human embryos
(3,798 genes × 90 cells). The synthetic dataset was simulated using our in-house
simulation method (see Section 2.3.2). It contains 22,846 genes and 100 samples. A total
of 10 co-regulated modules was embedded in this dataset, covering 2,240 up-regulated
genes. The E. coli RNA-Seq data consists of 4,497 genes and 155 samples, which was
integrated and aggregated by our group. In short, 155 fastq files were downloaded from
ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ using the sratoolkit (v2.8.1, https://github.com/ncbi/sratools/wiki/Downloads), and they are processed following quality check (FastQC), reads
trimming (Btrim), reads mapping (HISAT2) and transcript counting (HTSeq). Then, raw
read counts were RPKM normalized. The human RNA-Seq data contains 3,084 genes
and 8,555 samples, which was obtained from [70]. The scRNA-Seq data was downloaded
from [95] as an RPKM expression matrix with 20,214 gene and 90 cells, and then 3,798
genes were kept for the analysis in this study by removing the genes without annotation.
Multiple sets of known modules/biological pathways were provided or collected to
support the enrichment analysis of the above four datasets. For synthetic data, the ten
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groups of pre-defined up-regulated genes were used as co-regulated modules. For E. coli
data, we used five kinds of biological pathways, which are complex regulons and regulons
extracted from the RegulonDB database (version 9.4, accessed on 05/08/2017), KEGG
pathways collected from the KEGG database (accessed on 08/08/2017), SEED subsystems
from the SEED genomic database (accessed on 08/08/2017) [96], and EcoCyc pathways
from the EcoCyc database (version 21.1, as of 08/08/2017) [97]. Complex regulons
(ComTF) were defined as a group of genes that are regulated by the same transcription
factor (TF) or the same set of TFs. In total, 457 complex regulons, 204 regulons, 123 KEGG
pathways, 316 SEED subsystems, and 424 EcoCyc pathways were retrieved, respectively.
For the human TCGA and scRNA-Seq data, we used three sets of modules provided by
[70].
2.3.2 Simulation of Co-regulated Gene Expression Data
We utilized a single cell RNA-Seq dataset of human melanoma [98] (with 22,846
genes and 4,645 cells) to simulate bulk tissue RNA-Seq data with known co-regulated
modules. Specifically, a single cell RNA-Seq pool consists counts data of 4,466 cells of
six annotated cell types namely B-, T-, endothelial, fibroblast, macrophage, and cancer
cells were constructed. The top 1,000 cell type specifically expressed genes of each cell
type were identified by using Z score of the mean of each gene’s expression level in each
cell type.
For each round of simulation, the number of to be simulated bulk tissue samples
and co-regulation modules is first defined. Then the genes of each co-regulation module
denoted as 𝑋 will be specified by randomly selecting 𝑀 genes from the top 1,000 cell
type specifically expressed genes of one cell type. A co-regulation strength matrix 𝑃 is then
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simulated from a bimodal distribution over (0,1), with 𝑃[𝑖, 𝑘] denotes the proportion of
cells with the transcriptional regulatory signal of co-regulation module 𝑘 in bulk sample 𝑖.
A bulk tissue data is simulated by randomly drawing cells from the cell pool by following
a multinomial distribution, with predefined parameters and the total number of cells. For
co-regulation module 𝑘 in bulk sample 𝑖, genes 𝑋 in a proportion 𝑃[𝑖, 𝑘] of the selected
cells of the cell type corresponds to 𝑘 are perturbed by an X-fold increase of the gene
expression. Then the bulk data 𝑖 with simulated co-regulations are formed by summing the
perturbed gene expression profile the selected cells and normalized to RPKM expression
scale. The Pseudo code of the simulation approach is provided as follows:
𝐹𝑜𝑟 𝑘 𝑖𝑛 1 𝑡𝑜 # 𝑜 − 𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒𝑠
𝑋 ≜ 𝑅𝑎𝑛𝑑𝑜𝑚𝑙𝑦 𝑠𝑒𝑙𝑒 𝑡 𝑀

𝑒𝑛𝑒𝑠 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒 𝑒𝑙𝑙 𝑡𝑦𝑝𝑒 𝑠𝑝𝑒 𝑖𝑓𝑖 𝑎𝑙𝑙𝑦 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑒𝑑 𝑒𝑛𝑒𝑠 𝑜𝑓 𝑜𝑛𝑒 𝑒𝑙𝑙 𝑡𝑦𝑝𝑒

𝐹𝑜𝑟 𝑖 𝑖𝑛 1 𝑡𝑜 #𝐵𝑢𝑙𝑘 𝑡𝑖𝑠𝑠𝑢𝑒 𝑑𝑎𝑡𝑎
𝐹𝑜𝑟 𝑘 𝑖𝑛 1 𝑡𝑜 # 𝑜 − 𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒𝑠
𝑅𝑎𝑛𝑑𝑜𝑚𝑙𝑦 𝑠𝑖𝑚𝑢𝑙𝑎𝑡𝑒 𝑃[𝑖, 𝑘] ≜ 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓 𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑎 𝑝𝑒𝑟𝑡𝑢𝑟𝑏𝑒𝑑 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛
𝐹𝑜𝑟 𝑖 𝑖𝑛 1 𝑡𝑜 #𝐵𝑢𝑙𝑘 𝑡𝑖𝑠𝑠𝑢𝑒 𝑑𝑎𝑡𝑎
𝑅𝑎𝑛𝑑𝑜𝑚𝑙𝑦 𝑠𝑒𝑙𝑒 𝑡 𝑁 𝑒𝑙𝑙𝑠 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒 𝑒𝑙𝑙 𝑝𝑜𝑜𝑙 𝑤𝑖𝑡ℎ 𝑎 𝑚𝑢𝑙𝑡𝑖𝑛𝑜𝑚𝑖𝑎𝑙 𝑑𝑖𝑠𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑟𝑒𝑝𝑙𝑎 𝑒𝑚𝑒𝑛𝑡
𝐹𝑜𝑟 𝑘 𝑖𝑛 1 𝑡𝑜 # 𝑜 − 𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒𝑠
𝐶ℎ𝑜𝑜𝑠𝑒 𝑃[𝑖, 𝑘] 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓 𝑒𝑙𝑙𝑠 𝑜𝑓 𝑡ℎ𝑒 𝑒𝑙𝑙 𝑡𝑦𝑝𝑒 𝑜𝑟𝑒𝑠𝑝𝑜𝑛𝑑𝑠 𝑡𝑜 𝑡ℎ𝑒 𝑜𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒 𝑘
𝑃𝑒𝑟𝑡𝑢𝑟𝑏 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑋 𝑖𝑛 𝑡ℎ𝑒 ℎ𝑜𝑠𝑒𝑛 𝑒𝑙𝑙𝑠 𝑏𝑦 𝑎 𝑋 − 𝑓𝑜𝑙𝑑 𝑖𝑛 𝑟𝑒𝑎𝑠𝑒
𝑆𝑖𝑚𝑢𝑙𝑎𝑡𝑒 𝑡ℎ𝑒 𝑖𝑡ℎ 𝑏𝑢𝑙𝑘 𝑡𝑖𝑠𝑠𝑢𝑒 𝑑𝑎𝑡𝑎 𝑏𝑦 𝑠𝑢𝑚 𝑜𝑓 𝑡ℎ𝑒 𝑝𝑒𝑟𝑡𝑢𝑟𝑏𝑒𝑑 𝑒𝑛𝑒 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑠𝑒𝑙𝑒 𝑡𝑒𝑑 𝑁 𝑒𝑙𝑙𝑠

The rationales of this simulation approach include (1) gene expression level and
noise in the bulk data are purely simulated by sum of real single-cell data, without using
artificially assigned expressions scale and noise; (2) co-regulation genes are modeled as a
specific fold increase of a number of cell-type-specific genes in a particular subset of the
cells, which characterizes the heterogeneity of transcriptional regulation among cells in a
tissue; (3) multiple co-regulation modules in specific to different cell types can be
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simultaneously simulated. Hence, we believe the gene expression data simulated by this
way can satisfactorily reflect genes co-regulated by a perturbed transcriptional regulation
signal in real bulk tissue data.
2.3.3 Evaluation of Functional Modules
The capability of algorithms to recapitulate known functional modules are assessed
using precision and recall. First, for each identified bicluster, we use the P-value of its most
enriched functional class (biological pathway) as the P-value of the bicluster. Specifically,
the probability of having 𝑥 genes of the same functional class in a bicluster of size 𝑛 from
a genome with a total of 𝑁 genes can be computed using the following hypergeometric
function[99]:

P(𝑋 = 𝑥 𝑁, 𝑝, 𝑛) =

𝑝𝑁
𝑥

(1−𝑝)𝑁
−𝑥
𝑁

where 𝑝 is the percentage of that pathway among all pathways in the whole genome. The
P-value of getting such enriched or even more enriched bicluster is calculated as:

𝑃 − value = P(X ≥ x) = 1 − P(X < x) = 1 − ∑

𝑥−1 𝑝𝑁
𝑖
𝑖=

(1−𝑝)𝑁
−𝑖
𝑁

The bicluster is deemed enriched with that function if its P-value is smaller than a
specific cutoff (e.g., 0.05).
Given a group of biclusters identified by a tool under a parameter combination, the
precision is defined as the fraction of observed biclusters significantly enriched with the
one biological pathway/known modules (Benjamini-Hochberg adjusted p<0.05),
𝑃𝑟𝑒 𝑖𝑠𝑖𝑜𝑛 =

# 𝑜𝑓 𝑠𝑖 𝑛𝑖𝑓𝑖 𝑎𝑛𝑡 𝑏𝑖 𝑙𝑢𝑠𝑡𝑒𝑟𝑠
# 𝑜𝑓 𝑏𝑖 𝑙𝑢𝑠𝑡𝑒𝑟𝑠
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For recall, we compute the fraction of known modules that were rediscovered by
the algorithms,
𝑅𝑒 𝑎𝑙𝑙 =

# 𝑜𝑓 𝑠𝑖 𝑛𝑖𝑓𝑖 𝑎𝑛𝑡 𝑚𝑜𝑑𝑢𝑙𝑒𝑠
# 𝑜𝑓 𝑚𝑜𝑑𝑢𝑙𝑒𝑠

Finally, the harmonic mean of precision and recall were calculated to represent the
performance of an algorithm on a given dataset and parameter setting, denoted as F score:
𝐹=

2
1
1
𝑃𝑟𝑒 𝑖𝑠𝑖𝑜𝑛 + 𝑅𝑒 𝑎𝑙𝑙

Note that the number of biclusters used to calculate precision and recall may
affect the results. To make sure the evaluation is as fair as possible, for each dataset, we
select the first 30 biclusters.
2.3.4 Biclustering Parameters
To assess the robustness, each tool is run multiple times by varying parameters that
affect the size and number of biclusters. In general, parameters are adjusted around their
default or recommended (if available) value. The parameters varied as well as details about
the range and increment are listed in Table2.
Table 2. Main parameter adjusted for each algorithm
Algorithm
Bimax

Implementation
R package ‘biclust’

Parameters
minr ranges from 10~60(increment 5)
minc ranges from 10~45 (increment 5)
number set to 100

Note
Need discretized data as
input. For each dataset,
take the discretized data
from QUBIC as input.
No recommendation
provided by the author
or biclust manual.
Default: minr=2,
minc=2

ISA

R package ‘isa2’

set.seed ranges from 10~600, increment 10

ISA is stochastic, by
setting different seeds
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may obtain different
biclusters
R package fabia‘

FABIA

alpha ranges from 0~0.05,
increament:0.01;
spl ranges from 0~2, increment 0.5;

default: alpha=0.1, spl
=0, spz=0.5, cyc=500,
p=5

spz ranges from 0~2, increment 0.5;
cyc=100, p=100
R package ‘biclust’

Plaid

both row.release and col.release range
from 0.5~0.7, increment be 0.05
max.layer 10~100

QUBIC

R package
‘QUBIC’

f 0.1~1.0, increment 0.05
c 0.8~1.0, increment 0.05

for row.release and
col.release, 0.5~0.7 is
the recommended range
default: f=1.0, c=0.95,
k=ncol/20

k 3~23, increment 5
QUBIC2

C++

f 0.25~1.0, increment 0.05
k 5~23, increment 5

2.3.5 Results
Compared with five biclustering algorithms (Bimax [30], ISA [100], FABIA [37],
Plaid [16], and QUBIC [31]), the performance of QUBIC2 in identifying FGMs was
systematically evaluated using four gene expression datasets. For the identified biclusters
from a specific tool, precision showcases the fraction of biclusters whose genes are
significantly enriched with specific biological pathways (i.e., relevance), and recall
reflects the fraction of captured known modules/pathways among all known modules in a
functional annotation database, e.g., KEGG [101] and RegulonDB [102] (i.e., diversity).
The harmonic mean value of precision and recall, referred to as the F score, was used as
the integrated criteria in performance evaluation.
Evaluation studies usually used default parameters of the to-be-analyzed tools,
which were optimized for specific benchmark datasets. However, when applied to
datasets coming from a different organism (e.g., E. coli vs. human), or be acquired by
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other technologies (e.g., microarray vs. RNA-Seq), the default parameters often fail to
achieve satisfying performance and need further optimization/adjustment. To minimize
the biases in performance comparison among multiple tools, for each of the four datasets,
we run the six tools under more than 50 parameter combinations by adjusting their
critical parameters around default/recommended values. Then the F score of identified
biclusters under each parameter combination was calculated. In this way, we can test a
tool’s robustness and infer how sensitive of its performance is to parameter adjustment,
besides the basic performance comparison among different tools.
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As showcased in Figure 4, QUBIC2 achieved the highest median F scores and the
highest F scores with the default parameter on all the four datasets, and its F scores were
significantly higher than the second-best algorithms in all the comparison circumstances
(Wilcoxon test P-value <0.01). QUBIC2 performed well in both precision and recall,
indicating that the identified FGMs are relevant and diverse; and it had relatively small
variance, while the performance of some algorithms on specific dataset was susceptible to
parameter change (e.g., FABIA on E. coli). Regarding median F scores, QUBIC was the
second-best algorithm on simulated data, E. coli RNA-Seq data, and human scRNA-Seq
data, while FABIA was the second-best one for TCGA data. As regards the default settings,
QUBIC ranked as the top ones on simulated data and E. coli data, and ISA and Plaid had
relative higher rank on TCGA data. ISA was generally very stable, and its variances were
the smallest on three datasets. As for Bimax, although its recall was relatively low, it was
characterized with high precision on the four datasets. It is noteworthy that QUBIC2 is the
only program, among all the six biclustering algorithms, which did not encounter a
dramatic performance drop on scRNA-Seq data compared to RNA-Seq data, suggesting
the unique applicative power of QUBIC2 on FGMs detection from scRNA-Seq data.
Furthermore, the performance of all the biclustering algorithms on E. coli data was
better than on human data, with the possible reason that E. coli data has more completed
functional annotation and affects the evaluation of module significance. Therefore, for less
annotated organisms, we need a statistical evaluation framework for all the identified
biclusters.
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2.4 A Statistical Evaluation Framework for Identified Biclusters
The significances of gene modules from the identified biclusters were usually
evaluated by pathway enrichment analysis. However, many organisms (including human)
have limited functional annotations supported by experimentally verifications, which
makes a systematic evaluation of all identified biclusters non-trivial. To fill this gap, a
statistical method was proposed in QUBIC2, which can calculate a P-value for a bicluster
purely based on their size. To evaluate the validity of the proposed method, a Spearman
correlation test was conducted.
2.4.1 Methods
QUBIC2 was run on the E. coli RNA-Seq data under 63 parameter settings. For
each setting, around 100 biclusters were identified. Five sets of regulatory or metabolic
pathways were extracted from four databases of E. coli (RegulonDB, KEGG, SEED [96]
and EcoCyc [97]) to support this association study. In specific, for each set of ~100
biclusters obtained under the same settings, six groups of P-values for all these biclusters
were calculated, with five groups of P-values derived via pathway enrichment analysis
(named knowledge-based P-values) and one group of P-values computed using our sizebased method. Spearman correlation test was conducted to investigate the rank-order
correlation among the six groups of P-values. Five correlation coefficients (ρ), which
demonstrated the extent of correlation between size-based P-values and five biological
knowledge-based P-values, as well as five corresponding p-values, were recorded from the
test. Note that the p-value of correlation test denotes the probability of observing such a
correlation or even stronger correlation, under the null hypothesis that no correlation exists.
For simplicity, the correlation coefficient between the size-based P-value and biological
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knowledge-based P-value was prefixed with the name of a pathway, e.g., TF_ρ and
KEGG_ ρ . In the end, a total of 5 × 63 ρ (63 parameter settings, each with five ρs) and
the same number of p-values were obtained.
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Figure 5.A. The distribution of correlation coefficients(ρ) between P-value obtained from
enrichment analysis and size-based P-value. We run QUBIC2 under 63 different parameter
settings, and ρ was calculated under each run; B. Scatter plot of ρ and p-value. The y-axis denotes
ρ, the correlation coefficient for the Spearman association test, the x-axis denotes the p-value of
the association test. Note that to distinguish, italic lowercase p was used to denote the p-value of
the Spearman correlation test, while italic uppercase P was used to denote the significance of
biclusters.

2.4.2 Results
Interestingly, we found that there is a strong association between the knowledgebased P-value and the corresponding size-based P-values. The average Spearman
correlation coefficients (ρ) were higher than 0.40 (ComTF_ρ =0.48, TF_ρ=0.56, KEGG_ρ
=0.42, SEED_ρ=0.43 and ECO_ρ =0.42), and the average p-values for the correlation test
were smaller than 0.01. As showcased in Figure 5A, all the ρs in the five groups are
positive. Besides, ρs related with regulatory pathways (i.e., TF_ ρ and ComTF_ ρ) were
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generally larger than ρ s those related to metabolic pathways (i.e., KEGG_ ρ and
SEED_ ρ). This indicated that the size-based P-value seemed to be more suitable for the
evaluation of biclusters’ regulatory significance. Furthermore, all the corresponding pvalues were less than 0.05 (Figure 5B), suggesting that the correlations between
knowledge-based P-values and size-based P-values were statistically significant at the 0.05
level. Also, the parameter f which controls the level of overlaps between biclusters had a
negative association with ρ (Figure 6), suggesting that the size-based P-values would have
a stronger association with knowledge-based P-values when the overlaps between
biclusters are relatively low.
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Figure 6. The relationship between biclustering parameter f and correlation coefficient that
indicates the association between biological knowledge-based P-value and size-based P-value.
The blue line in each plot corresponds to the Loess smooth line.
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2.5 Cell Type Classification Based on scRNA-Seq Data
The above sections demonstrated the outstanding performance of QUBIC2 on
FGMs identification and its unique feature of statistical evaluation for all the identified
biclusters. In this section, we showed the predictive power of biclustering methods on cell
types identification from scRNA-Seq data.
2.5.1 Cell Type Classification Pipeline
By using biclustering, we can group genes and cells simultaneously. However,
since biclustering aims to find sets of genes that are co-expressed across a subset of
conditions, it is possible that genes may co-expressed across multiple cell types.
Therefore, one bicluster may consist of cells from different types, and cells from the same
types may appear in different biclusters. In a word, it is not guaranteed that one bicluster
corresponds to one cell type. However, it is assumed that two cells from a bicluster are
more likely to be of the same subtypes than the two cells that are randomly selected. It is
believed that biclusters can capture this feature to some extent. If there are multiple
biclusters and when we condense them together, we can distinguish sets of cells
belonging to the same type from sets of cells that are grouped by chance.
Based on the above idea, we developed a pipeline to obtain cell type classification
based on biclustering results (Figure 7A). First, a biclustering tool was applied to the
expression data (rows represent genes and columns represent cells) to identify a set of
biclusters. Then a weighted graph 𝐺 = (𝐶, 𝐸) was constructed to model the relationship
between cell pairs among biclusters. A node
the edge connecting

𝑖

and

𝑖

in 𝐺 represented a cell, and 𝑒𝑖, represented

, where 𝑖 ≠ 𝑗. We assigned weight 𝑤𝑖, to 𝑒𝑖, to represent the

number of biclusters that contain both

𝑖

and

. Intuitively, a higher 𝑤𝑖, value indicates
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that

𝑖

and

are simultaneously involved in more biclusters, hence, are more likely to be

the same cell type than cell pairs with lower weight. A symmetrical cell-cell matrix with
diagonal as 0 was then constructed to record 𝑤𝑖, and Markov Cluster Algorithm (MCL)
was performed to cluster cells into cell types and produce cell labels. In specific, the MCL
clustering was run 100 times by varying inflation factor from 1 to 100, resulting 100 cell
labels. A binary similarity matrix was constructed for each cell label: if two cells belong to
the same cluster, their similarity is 1; otherwise, the similarity is 0. Then a consensus matrix
was built by averaging all similarity matrices. The resulting consensus matrix was clustered
using hierarchical clustering with complete agglomeration, and the clusters were inferred
at the k level of the hierarchy, where k is the chosen based on the average silhouette score
of that 100 MCL clustering results.
2.5.2 Data, Biclustering Parameters and Evaluation Criteria
One golden-standard scRNA-Seq data [95] was used. It consists of 20,214 genes
and 90 cells, where the cells were assigned into seven subgroups with the true cell
subtypes information provided in [95].
For each of the six biclustering methods, we applied the classification pipeline to
the above dataset. Each tool was run under multiple parameter settings. The details about
the range of parameters are given in Table3.
Table 3. Parameter ranges for each biclustering algorithm used in the cell type
classification section
Algorithm
Bimax

Parameters
minr 10~200, increment 10
minc 10~30, increment 10
number=2000

Note
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ISA

set.seed ranges from 10~600, increment 10

FABIA

alpha 0.01~0.5, increment 0.01
spl 0~2, increment 0.05;

tried to set p=100, 1000, 2000, but
got error message ‘too many
biclusters’ and aborted

spz 0~2, increment 0.05
p=50
Plaid

row.release 0.5~0.7
col.release 0.5~0.7
max.layer 10~100

QUBIC

f 0.5~1.0, increment 0.05;

default o=100

c 0.8~0.95, increment 0.05;
k =13;
o =2000
QUBIC2

f 0.6~1.0, increment 0.05;
c 0.8~0.95, increment 0.05;
k = 4,13
o = 2000

The Adjusted Rand Index (ARI) was adopted as the evaluation criteria to access the
agreement between predicted cell types and these ‘ground truth' [103]. Two more external
validation criteria, namely Jaccard Index (JI) and Fowlkes Mallows Index (FMI), were also
used here aiming to provide a comprehensive evaluation.
Specifically, external validation measures the extent to which cluster labels match
externally supplied class labels. Generally, they are based on counting the pairs of points
on which two classifiers agree/disagree. Denote two partitions of the same data set as R
and Q. The reference partition, R, encode the class labels, i.e., it partitions the data into k
known classes. Partition Q, in turn, partitions the data into v categories, which is the one
to be evaluated.
Adjusted Rand Index (ARI) is defined as
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(𝑎 + )(𝑎 + 𝑏)
𝑑
𝐴𝑅𝐼 =
(𝑎 + ) + (𝑎 + 𝑏) (𝑎 + )(𝑎 + 𝑏)
−
2
𝑑
𝑎−

a: Number of pairs of data objects belonging to the same class in R and the same
cluster in Q.
b: Number of pairs of data objects belonging to the same class in R and different
clusters in Q.
c: Number of pairs of data objects belonging to different classes in R and the same
cluster in Q.
d: Number of pairs of data objects belonging to different classes in R and different
clusters in Q.
Terms a and d are measures of consistent classifications (agreements), whereas
terms b and c are measures of inconsistent classifications (disagreements).
Jaccard Index is defined as:
𝐽𝐼 =

𝑎
𝑎+𝑏+

The Jaccard Index can be seen as a proportion of good pairs with respect to the sum
of non-neutral (good plus bad) pairs.
Folkes-Mallow's index is defined as
𝐹𝐼 =

𝑎
√(𝑎 + 𝑏)(𝑎 + )

Fowlkes–Mallow's index can be seen as a non-linear modification of the Jaccard
coefficient that also keeps normality.
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2.5.3 Results
The performance of QUBIC2 was compared with five biclustering methods
(QUBIC, FABIA, ISA, Plaid and Bimax) and three cell type prediction methods
(SC3[95], SINCERA[104], and SNN-Cliq[105]). It is found that the average ARI score,
as a representative, of QUBIC2 was 37%, 220%, 632%, 151%, and 185% higher than the
other five biclustering methods, respectively; and was 30%, 67% and 62% higher than
the three cell type prediction methods, respectively. QUBIC2 and QUBIC were the top
two biclustering tools, respectively, in terms of median values on the three criteria. Both
surpassed the performance of SC3 (median value from 100 runs, denoted by the red dash
line in each panel of Figure 7B). Besides, ISA always demonstrated the smallest variance
across the three validation criteria. The FMI values of each tool were more stable than the
other two values. Figure 7C showcased one cell type classification result obtained by
QUBIC2. The result was in good agreement with the reference cell labels and QUBIC2
correctly grouped the three major cell types (8_cell_embryo, Morulae, and
late_blastoCyst).
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Figure 7. A. Computational pipeline for cell type classification. This pipeline consists of three
steps: biclustering, generation of weighted cell-cell matrix and clustering using MCL; B.
Benchmark of QUBIC2 against five popular biclustering algorithms. Each panel shows the
similarity between the inferred labels and the reference labels quantified by ARI, FW and JI,
respectively. Each algorithm was applied >40 times to the same dataset. The three indices were
calculated for each run of the respective methods (black dots). Bars represent the median of the
distribution of black dots. The red dash lines correspond to the benchmark performance of SC3
(ARI: 0.6549, FMI: 0.7243, JI: 0.5671); C. Sankey diagram comparing the 7 clusters obtained
with SC3 (right layer) and 6 clusters obtained with QUBIC2 (left layer). The middle layer
corresponds to the seven reference clusters. The widths of the lines linking nodes from two layers
correspond to the number of cells they have in common.

2.6 Application of QUBIC2 on Temporal and Spatial scRNA-Seq Data
When spatial and temporal information is available, scRNA-Seq can reveal more
biological insights beyond cell types. In this section, QUBIC2 was applied on two
temporal (and) and two spatial scRNA-Seq datasets, respectively, to explore the temporal
and spatial organization of cells.
2.6.1 Data
The time series lung scRNA-Seq dataset (GSE52583) with 152 cells and 15,174
genes from was downloaded from http://www.cs.cmu.edu/~jund/scdiff/download/data/.
The cells were collected at three time points: E14, E16, and E18. Another time series
scRNA-Seq data with 527 cells and 13991 genes (GSE48968) was downloaded from the
GEO database, in which the RPKM values are available.
The Mouse olfactory bulb spatial transcriptomic data was downloaded from
[106], which contains 280 cells and 15,981 genes. Ståhl et al. [106] classified the cells
into five clusters that correspond to well-defined morphological layers. The cells use
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coordinates as IDs, and the cell layers information was manually extracted using the ST
viewer (https://github.com/SpatialTranscriptomicsResearch/st_viewer), based on the
coordinate information. The raw reads of mouse spatial scRNA-Seq data GSE60402 were
retrieved from the SRA database [107], and the RPKM values for it were calculated using
software packages TopHat [108] and Cufflink [109]. GSE60402 was split into three
subsets according to sample information. The detailed information of the selected and
divided datasets is listed in Table 4.
Table 4. Summary of GSE60402
GEO Accession ID

Data ID

Description

#Cells

#Genes

GSE60402

GSE60402-Mutant

From Gfra1 mutant sample

94

11094

GSE60402

GSE60402-Wildtype1

From wild type mouse 1

124

10037

GSE60402

GSE60402-Wildtype2

From wild type mouse 2

94

10714

2.6.2 Results
QUBIC2 identified five biclusters from GSE52583. Three of the five biclusters
contain time-specific cells. In particular, bicluster BC002 consists of cells exclusively
from E14; bicluster BC003 includes cells that only from E16; and bicluster BC004 has
cells coming from E18 (Figure 8A). Functional enrichment analyses of the component
genes from these three biclusters were carried out based on DAVID [110], and the results
showed that genes in BC002 mainly related to cell cycle, cell division, and mitosis;
BC003 genes were enriched with ribosome, translation, and structural constituent of
ribosome; and spliceosome-related genes were grouped in BC004.
In addition to identifying biclusters corresponding to specific time point, QUBIC2
can also be used to find biclusters with time-dependent patterns. Here QUBIC2 was used
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to analyze a scRNA-Seq data with mouse dendritic cells (DCs) collected at 1h, 2h, 4h and
6h after treatment with pathogenic agent lipopolysaccharide (LPS) and untreated controls
(GSE48968) [111]. In total, 51 biclusters were identified in the datasets treated with LPS.
For each bicluster, the Fisher exact test was conducted on its constituting samples to assess
if significant over-representation by any time points could be found within the bicluster.
For those biclusters showing significant association with the time-course, a pathway
enrichment analysis was conducted to infer the biological characteristics of the bicluster.
In detail, pathway enrichment analysis is undertaken and the statistical significance of each
enriched pathway is assessed by using a hypergeometric test (statistical significance cutoff
= 0.005) against 4,725 curated gene sets in the MsigDB database, which includes 1,330
canonical KEGG, Biocarta and Reactome pathways, and 3,395 gene sets representing
expression signatures derived from experiments with genetic and chemical perturbations,
together with 6,215 Mouse GO terms each containing at least 5 genes [112, 113]. In the
end, 30 biclusters that are significantly over-represented by one or several consecutive time
points were identified in the LPS dataset (α=0.005, P<1e-22), and six of them showed clear
time dependence (Figure 8B). Specifically, bicluster BC013 consists of untreated samples
and samples collected at 1h, which represents the earliest response to LPS and enriches
multiple immune response pathways. Bicluster BC005 consists mainly of untreated
samples and samples collected at 1h and 2h, which also is enriched with immune response
pathways but with more responses to a virus, T cell chemotaxis and so on. BC009 and
BC001 are enriched by samples collected at 1h and 2h, covering a wider range of stressresponse pathways, suggesting that the activation of stress response pathways and altered
metabolisms as secondary responses after the early immune response. BC025 and BC002
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consist of samples collected at 4h and 6h, and their genes enrich pathways associated with
alterations in cell morphogenesis, migration, cell-cell junction and so on. Overall these
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observations suggest that our analysis can identify all the major responses to the LPS
treatment in a time-dependent manner.
Figure 8. A. Visualization of three biclusters (BC002, BC003, and BC004) selected based on the
specificity to time point; B. Time-dependent distribution of cells in six selected biclusters
identified in the LPS data. In each histogram, the five bars from left to right show the proportion
of the untreated samples and samples collected at 1h, 2h, 4h and 6h after the LPS treatment.

Then QUBIC2 was applied to a mouse spatial scRNA-Seq dataset with 280 cells.
The cells were classified into five clusters that correspond to five distinct morphological
layers in [106] (Figure 9A). Five biclusters were predicted. Among them, the bicluster
BC000 consists of cells mainly from the granular layer; the bicluster BC001 contains cells
from the mitral layer and glomerular layer; the bicluster BC002 includes cells mostly from
the olfactory nerve layer (Figure 9B). Functional annotation showed that BC000 mainly
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enriches plasma membrane, cell membrane, and cell projection; BC001 enriches synapse,
neuron projection, and cell projection; and BC002 enriches cell projection.
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Figure 9. A. The coordinates of cells correspond to five morphological layers (1. Granular cell
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20plexiform layer; 4. Glomerular layer; 5. Olfactory nerve
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layer); B. The coordinates of cells from three selected biclusters; C. The spatial coordinates of
samples in the four biclusters identified in wild-type 1 mouse; Colors red, green, cyan and dark
blue represent samples in four different biclusters; D. In addition to the coordinates of bicluster
samples, the yellow cubes represent significant outlier samples; E. The same information as in C
except the samples are from wild-type 2 mouse; F. The same information as in D except the
samples are from wild-type 2 mouse.

Finally, another spatial scRNA-Seq dataset (GSE60402) with samples dissected
from three mouse medial ganglionic eminence tissues and known spatial coordinates was
analyzed. QUBIC2 was applied, and 37, 40, and 120 biclusters were identified in the
mutant, wild-type 1, and wild-type 2 datasets, respectively. Further investigation on the
spatial distribution of cells in each bicluster showed that all the four spatial biclusters
with distinct expression patterns by cell cycle, cell morphogenesis, and neuron
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development genes, as reported in the original study [114], were identified by QUBIC2.
It is noteworthy that the outliers with highly expressed stem cell markers tend to be
located at the intermediate region between two adjacent (or overlapping) biclusters in the
three datasets as shown in Figure 9D and 9F. Our interpretation is that these locationdependent expression patterns may be caused by parallel and independent differentiations
from common stem cells.
2.7 Summary
The combination of biclustering and large-scale gene expression data holds a
promising potential in elucidating the functional pathways/networks encoded in a
genome. However existing biclustering tools fail to generate satisfactory results from
high-resolution RNA-Sequencing (RNA-Seq) data due to the lack of full consideration of
(i) intrinsic characteristics of RNA-Seq data, e.g., the massive zeros in both bulk and
scRNA-Seq data, and (ii) the underlying transcriptional regulation signals of gene
expression. Here we presented a novel biclustering algorithm, QUBIC2, for the analysis
of large-scale bulk RNA-Seq and scRNA-Seq data. QUBIC2 (i) used a truncated model
to handle the unquantifiable errors caused by zeros, (ii) adopted an informationdivergency objective function to optimize to-be-identified biclusters, (iii) utilized a CoreDual strategy to recruit novel genes and optimize parameters in identifying a bicluster,
and (iv) developed a size-based P-value calculation method to evaluate the statistical
significances of all the identified biclusters.
Our method validation on comprehensive data sets showed that QUBIC2 had
significant advantages in the functional module detection area, outperforming five
widely-used biclustering methods. The proposed P-value calculation method based on
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bicluster size did make sense, which may facilitate the evaluation of all the identified
biclusters, especially from less-annotated organisms. The cell type classification pipeline,
based on QUBIC2, worked well and outperformed the state-of-the-art performance of
SC3. By utilizing time-dependent data, QUBIC2 discovered biclusters specific to time
point and identified a cascade of immune responses to the external pathogenic treatment.
From the spatial transcriptomic data, QUBIC2 discovered that spatially adjacent single
cells might have high co-expression patterns, and particularly, two distinct spatially
clustered cells may be derived initially from the same stem cell. We believe that QUBIC2
can serve biologists as a useful tool to extract novel biological insights from large-scale
RNA-Seq data.
Although the advantages mentioned above, to fully excavate the potential of
scRNA-Seq data, there are several shortcomings needed to be overcome. First, as
sequencing costs decrease, larger scRNA-Seq datasets will become increasingly common;
thus, the scalability to large dataset and efficiency of tools will become more and more
critical. Currently, the discretization and Dual searching functions of QUBIC2 are timeconsuming on large-scale datasets. Based on our test, it takes 17 minutes to discretize a
dataset with 4,297 rows and 466 columns (a desktop with 48.0GB memory, Intel Core i76700, and 3.40GHz). Given a dataset with 22,846 genes and 100 conditions, the running
time while using Dual strategy are generally 2 minutes longer than that without Dual. The
OpenMP method will be implemented in the EM steps for discretization, and more efficient
heuristics algorithm will be designed to optimize the dual searching of biclustering.
Another challenge involves the interpretation of time-series and spatial data. For
example, in the GSE52583 data, QUBIC2 could only separate cells collected at different
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time points, yet the further differentiation stage information was not captured. For the
mouse olfactory bulb data, QUBIC2 did not separate cells from adjacent layers. To deal
with this drawback, we need to combine biclustering with other statistical methods
specifically designed for time series and spatial gene expression data.
It is noteworthy that many other kinds of methods can be used for gene expression
data analysis. Forty-two module detection tools covering five main approaches were
reviewed in [70], and the authors concluded that decomposition methods outperformed
all other strategies, including biclustering methods. Meanwhile, they also observed that
QUBIC and FABIA had higher performance on human and synthetic data. We compared
two top-rated decomposition methods and two top clustering methods with QUBIC2 and
QUBIC on a human scRNA-Seq data; the results showed that QUBIC2 surpassed both
decomposition and clustering methods (Figure 10). In the future, we will carry out a
more comprehensive comparison between QUBIC2 and other decomposition and
network-based methods, aiming to give a systematical evaluation of the power of
computational techniques on scRNA-Seq data.
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Figure 10. Performance of QUBIC2, QUBIC, two decomposition methods and two clustering
methods in term of F score on a human scRNA-Seq data.
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CHAPTER 3: QUBICR- A Biconductor Package for Qualitative Biclustering Analysis of
Gene Co-expression Data
Biclustering is a widely accepted approach for gene expression data mining.
Several biclustering algorithms have been published in the past two decades, and QUBIC
has been reviewed as one of the best programs by several review studies. To enable the
biclustering users lacking comprehensive computational background, a web server of
QUBIC was developed in 2012 [23]. Since gene expression datasets keep increasing in
scale, we developed this user requested R package of QUBIC (QUBIC-R for short), to
provide an efficient optimized implementation and to eliminate large-scale data submission
to a webserver.
The unique features of QUBIC-R include: (i) biclustering is integrated with
analyses functions, i.e., data discretization, query-based biclustering, bicluster expanding,
biclusters comparison, heatmap visualization and co-expression network elucidation
(Figure 11A); (ii) the QUBIC source code is optimized and converted from GNU C to
C++, thus has better memory control and is more efficient than the original QUBIC (an
average 82.4% saving of running time); (iii) on five large-scale datasets, QUBIC-R
consistently performs the best among four popular tools according to the running time
(Figure 11B). In the following part, I will present the main features of QUBICR.
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Figure 11. A. Comparison of QUBIC-R and 6 R packages in biclust. Yellow color indicates that a
package provides the function or is recommended in a specific biclustering application and gray
color represents the opposite; B. Comparison of running time among four recommended
programs, annotated with asterisks in Figure 11A; C. Heatmap visualization of two biclusters
identified in E. coli data; D. Co-expression networks of Figure 11C biclusters. Green nodes
represent bicluster #3 and red nodes represent bicluster #7. The larger the size of a node, the
higher its degree of presence; and the thicker an edge the heavier its co-expression value is.
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3.1 Implementation
QUBIC-R package [115] is developed for the R statistical computing environment,
and is freely available at http://bioconductor.org/packages/release/bioc/html/QUBIC.html.
It depends on the biclust package developed by Kaiser et al. [48] to be compatible with the
biclust output. Its output format can also be used by network analysis software, such as
Cytoscape [116].
The original QUBIC program, written in GNU C with POSIX library, is limited
in its portability. A memory leak may occur if the primary functions are called more than
once. This problem was addressed by refactoring the C source code and transforming it
into C++. Specifically, to avoid memory leak, we changed the majority of data structures
and replaced C pointers by STL containers. We also optimized core function structures to
facilitate future package updates and developments. The program efficiency has been
significantly increased with the same predicting results (Figure 11A). An input data as
large as 30,000×30,000 can be finished within half an hour (detailed limits test is in Figure
12). All the computational experiments were conducted on a computer with Windows 7
x64, Memory 48G, Intel Core i7-6700 3.4G.
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Figure 12. Data limit test of QUBICR on simulated datasets. In this test, n-by-n matrixes were
generated with increasing number of n (1,000, 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000,
9,000, 10,000, 15,000, 20,000, 25,000, 30,000). Each matrix was planted with several nonoverlapped 10-by-10, 10-by-20, or 20-by-10 biclusters (corresponding to the 1:1,1:2 or 2:1 rowcolumn-ratio, respectively). Default parameters of QUBICR were applied (c=0.95, r=1, f=1,
q=0.06, o=100, k=max(ncol(x)%/%20,2)), and the running time in y-axis is in its log2 scale.

3.2 Functions
(i) qudiscretize is useful to obtain discrete gene expression matrix. This matrix
can be used in other biclustering program, where -1 represents lowly express, 0
represents normally express, and 1 represents highly express. For example:
library(QUBIC)
matrix1 <- ecoli[1:3, 1:4]
matrix1
##
dinI_U_N0025 dinP_U_N0025 lexA_U_N0025 lon_U_N0025
## b4634
9.077693
9.225537
9.138900
9.114353
## b3241
7.122300
7.195453
7.051193
7.124200
## b3240
7.184417
7.336610
7.283377
7.188263
matrix2 <- qudiscretize(matrix1)
matrix2
##
dinI_U_N0025 dinP_U_N0025 lexA_U_N0025 lon_U_N0025
## b4634
-1
1
0
0
## b3241
0
1
-1
0
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## b3240

-1

1

0

0

(ii) BCQU and (iii) BCQUD are used to perform biclustering for continuous and
discretized gene expression data, respectively:
# QUBic-R on continuous data
res <- biclust(ecoli, method = BCQU(), f = 0.25,verbose=F)
res
##
## Number of Clusters found: 19
##
## Cluster sizes:
##
BC 1 BC 2 BC 3 BC 4 BC 5
## Number of Rows:
437 121
51 108 103
## Number of Columns: 29
45
94
44
38
# QUBIC-R on discrete data
res1 <- biclust(x = qudiscretize(ecoli), method = BCQUD(), f = 0.25, ve
rbose=F)
res1
# QUBIC algorithm can be called independently via qubiclust and qubiclu
st_d for both continuous and discrete data, respectively:
res2 <- qubiclust(x = ecoli, f = 0.25, verbose=F)
res2
res3 <- qubiclust_d(x = qudiscretize(ecoli), f = 0.25)
res3
# note that res, res1, res2 and res3 are the same

(iv) Using the parameter weight, a user can conduct a query-based biclustering,
with additional biological information.
Specifically, a user can input additional biological information and utilize that
information to guide the biclustering progress in QUBICR, using the newly-added
parameter weight. This kind of function is so-called query-based biclustering and has been
widely applied in bioinformatics [24, 117] . The format of this input file should be
supported by igraph, e.g., a file with three columns with column #1 and #2 representing
the gene names and column #3 being the score of the two genes. QUBICR will (step 1)
rank all the gene pairs in this additional input file, according to the corresponding biological
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information (e.g., protein-protein interaction information or co-regulation relationship), in
an increasing order; (step 2) rank all the gene pair in original gene expression data,
according to their co-expression similarity trained from the QUBIC algorithm, in an
increasing order; and (step 3) add the two ranks together for each gene pair. Then the
summed ranks will be used as a new weight for each gene pair for all the following
biclustering procedures. It is noteworthy that if a gene pair appears in this additional input
file but not in original gene expression file (or in the opposite situation), its rank in step 1
will be assigned as 0.
In this example, the instance file “511145.protein.links.v10.txt” was downloaded
from string
(http://stringdb.org/download/protein.links.v10/511145.protein.links.v10.txt.gz). Note
that after using the weight parameter, the output biclusters changed.
# Conduct a query-based biclustering by adding the weight parameter
library(QUBIC)
library(QUBICdata)
data("ecoli")
library(igraph)
file = "511145.protein.links.v10.txt ";
graph = read.graph(file, format = "ncol")
get.edgelist(graph, names = TRUE)
E(graph)$weight
weight <- get.adjacency(graph, attr = "weight")
res0 <- biclust(ecoli, method = BCQU(),verbose = F)
res0
res4<- biclust(ecoli, method = BCQU(), weight = weight, verbose = F)
res4

(v) Using the seedbicluster parameter, a user can expand existing biclusters by
recruiting more genes according to specified consistency level. The existing biclusters can
be any biclustering results obtained from QUBICR or from any other algorithms in the
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biclust package. This function has been successfully applied in [118] and a flowchart of
this function can be found in Figure 1 of [118].
In the following example, we expand previously obtained biclusters by QUBICR
(res). Note that number of genes in some biclusters increase after expanding (e.g., 437
genes in BC1 from res vs 593 genes in BC1 from res5).
res5 <- biclust(x = ecoli, method = BCQU(), seedbicluster = res, f = 0.
25,verbose = F)
res5
##
## Number of Clusters found: 19
##
## Cluster sizes:
##
BC 1 BC 2 BC 3 BC 4 BC 5
## Number of Rows:
593 151
51 110 117
## Number of Columns: 29
45
94
44
38

(vi) Using the parameter showinfo, the biclustering results from different
algorithms or from a same algorithm with different combinations of parameter can be
compared. Specifically, we can compare the number of detected biclusters, the row number
and column number of the first bicluster, the area of the first bicluser, the overlap of first
two biclusters , and so on.
test <-ecoli [1:50,]
res6 <-biclust(test, method = BCQU(), verbose = F)
res7 <- biclust (test, method = BCCC())
res8 <- biclust(test, method = BCBimax())
showinfo (test, c(res6, res7, res8)

(vii) The function quheatmap can visualize the identified biclusters using heatmap
in support of overall expression pattern analysis, either for a single bicluster or for two
biclusters.
# heatmap for single bicluster
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par(mar = c(5, 4, 3, 5) , cex.lab = 1.1, cex.axis = 0.5, cex.main = 1.1
)
quheatmap(ecoli, res, number = 4)

Figure 13. Heatmap for the 4th bicluster identified in the E. coli data.
# heatmap for two biclusters
par(mar = c(5, 4, 3, 5) , cex.lab = 1.1, cex.axis = 0.5, cex.main = 1.1
)
quheatmap(ecoli, res, number = c(3,7))

(viii) We can construct and visualize network for the identified biclusters, using
the function qunetwork, either for a single bicluster or for two biclusters.
In the gene co-expression network, each node represents a gene, and a pair of nodes
is connected with an edge if they have a significant correlation (with the cutoff as 0.6 in
default). Specifically, for a single bicluster with m genes and n conditions, we used the mby-n expression matrix to calculate the correlation between each pair of genes in the
network. For two given biclusters, whose gene sets are {m1} and {m2} and condition sets
are {n1} and {n2}, we used the expression matrix, with genes |{m1∪m2}| and conditions
|{n1∪n2}|, to generate the correlation coefficient scores among genes. QUBICR provides
three methods to calculate the correlation, i.e., Pearson, Kendall and Spearman, to facilitate
different preference in practical application.
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# Construct the network for the 4th identified bicluster in the E.coli
data
library(qgraph)
net1 <- qunetwork(ecoli, res, number = 4, group = 4, method = "spearman
")
qgraph(net1[[1]], groups = net1[[2]], layout = "spring", minimum = 0.6,
color = cbind(rainbow(length(net1[[2]]) -

1), "gray"), edge.label = F)

Figure 14. Network for the 4th bicluster identified in the E. coli data.
# Construct the network for the 3th and 7th bicluster in the E.coli dat
a
net2 <- qunetwork(ecoli, res, number = c(3, 7), group = c(3, 7), method
= "spearman")
qgraph(net2[[1]], groups = net2[[2]], layout = "spring", minimum = 0.6,
legend.cex = 0.5, color = c("red", "blue", "gold", "gray"), edge.label
= FALSE)

(ix) The function qunet2xml can convert the constructed networks into XGMML
format, facilitating further functional enrichment analysis (e.g. DAVID) and advanced
network visualization (e.g. Cytoscape, Biomax and JNets)
# Output overlapping heatmap XML, could be used in other software such
# as Cytoscape, Biomax or JNets
sink("tempnetworkresult.gr")
qunet2xml(net2, minimum = 0.6, color = c("red", "blue", "gold", "gray")
)
sink()
# We can use Cytoscape, Biomax or JNets open file named
# tempnetworkresult.gr
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3.3 Summary
Biclustering algorithms facilitate researchers in the identification of co-expressed
gene subsets in their gene expression dataset and have become a useful approach for the
interpretation of gene expression profile data. Our R package implements a well-cited
biclustering algorithm, QUBIC. It provides more efficient source code and fully integrated
functions to identify and analyze biclusters and visualize identified biclusters and
corresponding co-expression networks. This package is a powerful tool for gene expression
data mining and co-expression network modeling.
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CHAPTER 4: Application of Biclustering on Biological and Biomedical Data
The advent of much-improved biotechnology and the decreased associated costs
have generated a massive amount of biological and biomedical data. NGS allows for
rapid generation of larger volumes of biological information than ever before. Also, large
amounts patient clinical data are generated through NGS and Electronic Health Record
(EHR), which presents significant opportunities for knowledge discoveries in biomedical
research [119]. These complex and large volumes of data, collected from different
sources, have changed the way biological and biomedical research is conducted [120,
121]. Effective utilization and interpretation of such data require advances in
interdisciplinary sciences. The concept of big-data-to-knowledge relies extensively on
biological, mathematical, statistical, and computer sciences to extract usable information
and generate new knowledge.
Furthermore, with the advancement of informatics technology, EHR contains
sufficient information that can be transformed into disease phenotypes [122]. In this
phenotyping process, a heuristic and the iterative searching algorithm is applied to search
the large-scale EHR database with queries created by clinical experts and knowledgeable
computational engineers [122], during which thousands of phenotypes generated for all
the included individuals. These phenotype data can be organized into a matrix, with
phenotype features as rows and individuals as columns, providing essential materials to
identify a family of phenotype biclusters. The biclusters define a subgroup of patients
from a subset of phenotypes, which are subject to detailed validation analysis to establish
their relations with (i) prognostic or therapeutic characteristics of diseases [123-126], and
(ii) genotype biclusters [122].
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As far as we know, application of biclustering has not progressed in parallel with
algorithm design. Considering all the biclustering-related publications, the portion of
application studies has been much lower than that of algorithm development studies from
the year 2000 to 2017 (Figure 15). This situation is affected by multiple factors. First, there
is a gap between tool development and the understanding of new biotechnologies and
corresponding data properties. For example, microarray data is reflecting absolute gene
expression with continuous fluorescence intensity values [127], while RNA-Seq data
measures the relative expression level using discrete, positive, and highly skewed read
counts [88, 128-130]. Furthermore, there are abundant zeros in RNA-Seq-based gene
expression data as not all the genes are expressed under a specific experimental condition,
which is particularly true in scRNA-Seq data [82, 131]. Hence, algorithms designed and
evaluated using microarray data may not be suitable to be directly applied to RNA-Seq
data. RNA-Seq and scRNA-Seq data need unique design in algorithm and tool
development. However, contrary to the fact that RNA-Seq is becoming more and more
popular, few biclustering algorithms are explicitly designed for RNA-Seq data [38, 39, 41,
42]. Second, there is a knowledge gap for applying biclustering tools and choosing the
appropriate accompanying analytical tools for specific data analyses. Usually, biclustering
is not a solo data analysis tool. Instead, it connects with other results annotation processes
(e.g., DAVID and KOBAS), visualization programs (e.g., Cytoscape), and statistical
methods (e.g., Principal Component Analysis and Regression Analysis), to derive a more
comprehensive interpretation. It is worth noting that organically integrating a biclustering
algorithm and appropriate accompanying tools into a pipeline is not trivial. Construction
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of a unified pipeline requires a deeper understanding of underlying algorithm designs, data
inputs, and expected outputs.
The yearly proportion of biclustering references related to algorithm development
and improvement and application studies are presented in Figure 15. The numbers of
biclustering studies on algorithm design and application were similar at the earliest stage
when few tools were available. The proportion of application related studies decreased
relative to algorithm design until 2010. In the 1,650 articles published in 2011, the number
of studies related to algorithm design was almost nine times that of the application studies.
Recently, more researchers have realized the biclustering application shortage and made
significant efforts in this area. Between 2012 and 2016, the application publication
proportion increased to 40%. There is still a considerable potential for more application
related studies; therefore, this review systematically summarizes the basic applications of
biclustering in biological data and the advanced applications of biclustering in biomedical
data. This information will enable biological researchers to select appropriate algorithms
and computational tools for their various studies, effectively bridging the gap between big
data and valuable biological knowledge and efficiently providing novel data-driven
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insights. In the following, we will review how biclustering aids biological and biomedical
data interpretation at the gene, module, and network level, respectively.

Figure 15. Yearly comparison of biclustering algorithm development and algorithm application
related studies. The references in 2017 were collected as of 03/26/2017. The overall annual
reference numbers that shown on the top of each bar were collected by searching the keyword
"biclustering" on google scholar, and proportion of algorithm development shown in blue was
captured by adding the keyword "algorithm," and the rest are considered as application related,
which were shown in orange.

4.1 Basic Application of Biclustering on Biological Data
It is well known that biological function can rarely be attributed to an individual
molecule. Instead, most functions arise from complex interactions (as a whole system or
module) among the cell’s numerous components, such as protein, DNA, RNA, and small
molecules [132, 133]. Biotechnology has developed very fast in the last two decades, from
traditional arrays (e.g., microarray and tilling array) to NGS (e.g., DNA-Seq, RNA-Seq,
and Chip-Seq) to the third-generation long read sequencing (e.g., PACBIO and Oxford
Nanopore). The generated data provide unprecedented opportunity to understand the
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complex biological system at different levels, from basic mutation, gene and protein
structure level, to pathway/module level, and even global networks. Biclustering analyses
play a significant role in making sense out of various omics data towards the goal of
generating a system-level understanding.
4.1.1 Functional Annotation of Unclassified Genes
Functional annotation categorizes genes into one or multiple functional classes,
which is an essential step for understanding the physiological purpose of target/interesting
genes. However, a reliable functional assessment of a given gene can be carried out only if
all its interacting genes are known in advance, as a gene can be involved in different
pathways/networks to achieve specific biological functions [134]. These are typically not
known for all genes or conditions. Biologists often deal with this challenge, in part, by
taking advantage of the “guilt-by-association” (GBA) principle. GBA assumes that
functions can be transferred from one gene to another through biological association. Two
kinds of information are required for a GBA-based functional annotation: known functional
annotation in public domain and the associations between annotated and unannotated
genes. NCBI, Gene Ontology [135], and KEGG [101] are three dominant representatives
of such comprehensive databases; RegulonDB is one of the most widely-used resources
for E. coli K-12 gene regulation [102]; The Cancer Genome Atlas (TCGA,
https://portal.gdc.cancer.gov/) offers genomics, epigenomic and proteomic data for
thousands of tumor samples across more than 20 types of cancer; and PlantTFDB provides
comprehensive genomic transcriptional factor (TF) repertoires of green plants [136]. For
unannotated genes, co-expression is one of the most widely used association indices, as
gene expression profile collection is accessible and can be used to derive other associations,

62
e.g., co-regulation [137, 138] and co-evolution [139, 140]. Biclustering can be used to
identify co-expressed genes based on the similarity of their expression profiles across a
wide range of conditions (e.g., treatments, tissues, and samples), giving rise to a set of
significant CEMs, i.e., biclusters [141]. Based on existing annotation databases and these
CEMs, functional enrichment analysis is carried out to identify significantly
overrepresented functions, using the hypergeometric distribution as a statistical test [99].
Highly enriched functions are assumed to be shared by all members in the obtained
biclusters, and unannotated genes in those biclusters will be assigned to the most abundant
functional class [142, 143]. It is noteworthy that biclustering is usually combined with the
comparative genomics strategy in the case of gene annotation for new-sequenced
organisms, which builds links between well-annotated model organisms and the new
organisms [144].
Despite the high potential of this approach, it is essential to keep in mind that
correlation does not guarantee causal relationships, i.e., genes with similar expression
profiles may not have the same function. The results should be interpreted as preliminary
computational predictions which provide useful hypothesis/candidates for future testing
[145]. Thus, experimental validation of the predictions is needed. However, the percentage
of unannotated genes is very high even in well-studied model organisms [93] (e.g., the
proportion of unannotated genes is around 40-50% in E. coli), and it is unrealistic to go
through all the to-be-validated candidates exhaustively using experimental methods.
Therefore, researchers usually just verify functions of a few genes of considerable interest
[142], and in most cases, they rely on computational validation (e.g., cross-validation [146]
and random forest [143]) and published literature support.
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The basic idea of computational validation is to mask the functions of some
annotated genes in a CEM and check to see if the functions can be correctly assigned back
to the masked genes. The validation could be conducted by assessing whether the genes
share conserved sequence motifs, as it is believed that co-expressed genes tend to, although
not necessarily, be transcriptionally co-regulated [147]. Recently, researchers proposed
using genome-scale ChIP-Seq data for the validation of the prediction of CEMs [144].
Table 5 summarizes five representative studies which inferred the functions of unannotated
genes from the well-annotated genes that they are co-expressed with. For each of five
studies, we introduce the input data for the study (Data), biclustering algorithm and
accompanying analysis methods (Methods), specific tool and software (Tools/Databases)
used to accomplish the research, the output and results (Outcomes), and related references
(Refs). All other tables in this study follow the same structure.
Table 5. Case studies of Functional annotation of unclassified genes
Data

Methods

Tools/Databases

Outcomes

Refs

Functional annotation of Yeast
Microarray
(6,200 ORFs
under 515
conditions)

• Biclustering for gene classification

SAMBA

• Functionally assign the unannotated genes in
biclusters to the most abundant class;

SGD [148]

• Cross-validation for annotation assessment.

-

2,406
biclusters;
196 annotations
of unknown
genes;

[146]

Functional annotation of plant genomes

Microarray
(21,031 genes
of Arabidopsis
under 351
conditions)

• Biclustering on known PCW genes;

QUBIC

• Expand biclusters to include additional
genes;

QUBIC

• Construct co-expression network;

Cytoscape
WeederTFBS;

• Predict and annotate motifs in promoter
regions of co-expressed genes in each
module.

MotifSampler
CompariMotif
PLACE

417 seed
biclusters;
2,438 candidate
PCW genes coexpressed with
349 PCW
genes.

[147]
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AGRIS

Microarray
(122,973
probes of
Switchgrass,
94 conditions)

• Homologous mapping of identified CW
genes;

Tblastn

• Assign mapped genes to CW-associated
functions;

DAVID

• Biclustering of mapped genes and expand
for new candidates;

QUBIC

104 clusters of
co-expressed
genes;

• Identify motifs for each bicluster;

-

823 new PCW
genes;

• Validate prediction by annotated
Arabidopsis CW genes

PCWGD *

991 homologs
CW genes;

[144]

112 new genes.

Functional annotation of Human and Mouse
• Identify lincRNA;
A correlation
matrix with
associations
among mouse
lincRNA,
protein-coding
genes, and
lincRNAs

• Create association matrix of lincRNA and
protein-coding genes;

GSEA

• Biclustering to identify functional modules
consisting of lincRNAs and protein-coding
genes;

SAMBA

• Assign putative functions to each lincRNA;

-

• Validate inferred biological functions for

-

lincRNAs.

65 human
microarray
datasets and
GO function
categories

ChIP-Seq

• Discover network patterns based on frequent
item sets and biclustering;

-

• Design network topology statistic based on
graph random walk;

-

• Assess functional annotation by a random
forest method.

-

Sets of
lincRNAs
associated with
a diverse range
of functions
including cell
proliferation,
immune
surveillance,
muscle
development,
etc..

[142]

1,126 functions
assigned to 895
genes (779
knowns and 116
unknowns).

[143]

Note: - denotes for no specific existed tools and this also applies to all the following tables.
* Purdue Cell-Wall-Genomics Database (https://cellwall.genomics. purdue.edu)

4.1.2 Modularity Analysis
Compared to individual cellular components, modularity analysis puts more
emphasis on the component’s relationship and the topology of a module, i.e., a group of
physically or functionally linked molecules that work together to achieve distinct functions
[133]. Increasing evidence indicates that biological systems are inherently modular [149-
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151], therefore, modularity analysis has been widely applied to investigate the organization
and dynamics of biological systems at different levels, i.e., module identification, module
dynamic analysis, and module network reconstruction. Up to now, substantial efforts are
devoted to the first level of modularity analysis, module identification.
Biclustering has been applied to identify different types of modules, which could
be groups of interacting molecules (e.g., miRNA sponge modules in [152] and miRNAmRNA modules in [153]), functionally related genes/proteins or any other manually
defined clusters [154]. Depending on the target modules, different inputs and strategies are
needed. For example, scRNA-Seq gene expression data was utilized to identify molecularly
distinct subtypes of cells that contribute different brain functions [155]; and an integrated
correlation matrix was derived from expression data with target site information to predict
miRNA-mRNA functional modules [153]; time series expression data provides valuable
information regarding the cellular dynamic activity, thus it is often utilized to identify
temporal transcriptional modules that consist of activated genes at consecutive time points
[38]. As various modules are investigated, additional supporting data are often involved.
For example, promoter sequences and integrated de novo motif detection are integrated
with co-expression biclustering to identify regulatory modules [61]. Similar strategies have
been implemented with the integration of other supporting data types (e.g., operon
prediction, ChIP-Seq data, and network connections) [53].
With modules identified, further research concentrates on investigating the
characteristics of modules. Applying functional annotation or enrichment analysis to these
modules can illustrate/deduce their roles in biological processes [152, 153, 156]. Where
expression profiles are available in multiple evolutionarily correlated species, researchers
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can conduct inter-specific comparisons and investigate the underlying evolutionary story.
For example, Waltman et al. performed biclustering of multiple-species data and then used
a conservation score to identify conserved modules among these species [157]. Based on
co-regulation modules, Yang et al. derived an expression-based quantity to characterize
the functional constraint acting on a gene, and then tested the correlation of those quantities
with gene Sequence divergence rate to estimate the evolutionary potential of genes [158].
With temporal modules, the dynamic regulatory interaction can be explored. Gonçalves et
al. [159] ranked TFs targeting the modules at each time point and graphically depicted the
regulatory activity in a module at consecutive time points. Other researchers examined the
external relationship among modules, e.g., grouped modules of host proteins based on a
distance measure to form higher-level subsystems [160]. Table 6 summarized four kinds
of modularity analysis applications, including functional module identification, regulatory
modules, evolution characteristic, and module subsystem. Module-based network
inference, as a higher level of modularity analysis, will be introduced in next section.
Table 6. Case studies of Modularity analysis.
Data

Methods

Tools/Databases

Outcomes

Refs

Four miRNA
sponge
modules

[152]

Functional Module

miRNA-mRNA
regulatory score matrix
derived from gene
expression data

• Create miRNA-mRNA regulatory
score matrix based on expression
matrix and miRNA-target binding
information;

-

• Biclustering on the score matrix to
infer miRNA-mRNA biclusters;

BCPlaid

• Filter biclusters using statistical
methods and interaction
information;
• Functional annotation;

-

GeneCodis
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mRNA-miRNA
association matrix derived
from gene expression data

SC-RNA-Seq (3,005
mouse cortical cells)

• Validation of predicted modules

-

• Construct mRNA-miRNA
association matrix based on
expression data and miRNA target
information;

-

• Biclustering to identify functional
modules;

BUBBLE

• Visualize and evaluate modules.

miRMAP

• Biclustering

100 putative
miRNA
functional
module

[153]

BackSPIN

47 distinct
cell
subclasses

[155]

450
regulatory
modules

[61]

600 modules

[53]

Regulatory modules
Microarray data (S.
cerevisiae under 2,200
conditions); upstream and
downstream Sequences.

• Biclustering

COALESCE

Microarray (M.
tuberculosis under 2,325
measurements); and 154
TFs ChIP-Seq data

• Biclustering

cMonkey2

• Biclustering

CCC-Biclustering

Time series expression
for 2,884 genes of
Saccharomyces cerevisiae
in response to heat stress
under five time-points

• Ranking the prioritize prominent
regulators targeting each the
modules at each time point
• Graphically depict the regulatory
activity in a module

Regulatory
Snapshots
Baiacu;
BiGGEsTs

167
biclusters;
Regulatory
snapshots of
documented
regulators at
each time
point

[38,
159]

Evolutionary study
Three normalized
expression matrixes (B.
subtilis, B. anthracis, and
L. monocytogenes);

• Biclustering on expression data;

FD-MSCM

upstream Sequences;
metabolic and signaling
pathways, co-membership
in an operon and
phylogenetic profile
networks
Microarray (4117
orthologs in 15, 14, and

• Evaluate the conservation between
biclusters

• Biclustering to predict coregulated modules;

150 biclusters

[157]

1,181
modules

[158]

-

ISA
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17 tissue groups in rice,
maize, and Arabidopsis,
respectively)

• Quantify the functional constraint
acting on a gene based on the
modules (eFC)

-

• Correlate eFC with gene Sequence
divergence rate

-

Subsystem
• Biclustering on the binary
interaction matrix;
HIV-1, Human Protein
Interaction Database
(HHPID)

Bimax

• Construct bicluster distance
matrix;

-

• Construct neighbor-joining tree
and designate host subsystem

-

279
significant
sets of host
proteins show
the same
interaction to
HIV-1

[160]

4.1.3 Biological Networks Elucidation
Biological interactions can be conceptualized as networks, with nodes representing
biological entries and edges denoting relationships between nodes. For example, in proteinprotein interaction (PPI) networks, nodes are proteins and edges represent physical
interactions; in transcriptional regulatory networks (TRNs), nodes stand for regulators
(TFs, microRNAs, and lncRNAs) and targets, and edges are regulatory interaction
directing from regulators to targets. Analyzing these networks provides systematic views
and novel insights in understanding underlying mechanisms controlling cellular processes.
Table 7 shows some examples in network analysis, mainly focus on network inference and
network decomposition.
Compared with random networks, one distinct characteristic of the biological
networks is modularity, forming dense subgraphs [161, 162]. Several computational
approaches have utilized the module-based method to infer networks. For example, in
TRNs, one widely used approach is to group genes/regulators based on the similarity of
their expression profile using biclustering, along with the modeling of the regulatory
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interactions between those modules to get a higher-level understanding of regulatory
mechanisms[132]. This approach has been successfully applied in several other studies
[163-165]. On the other hand, Tanay et al. [150] used the hierarchical topology of the
biological networks. They first used biclustering to identify modules based on integrated
heterogeneous experimental data, and then built a module graph, with nodes being modules
and edge connected two modules whenever their genes intersect sufficiently. These small
modules were clustered into supermodules based on their functional association. In this
way, a hierarchical transcriptional network was built. It is noteworthy that researchers often
integrate multiple sources of data, in the hope of getting a more comprehensive and
accurate view of biological networks. For example, TRNs were constructed using
expression data as well as Sequence information and interaction data[163-165]; and Tanay
et al. combined expression data, various interactions, and phenotypes [150].
Network decomposition breaks a network down into simpler units or components,
e.g. network motifs and modules, and is another hotspot in network analysis. Compared
with the previous modularity analysis section where biclustering method is mainly applied
to expression data, biclustering takes networks as input in decomposition. Decomposition
reduces network complexity and facilitates the exploration of the underlying molecular
mechanisms[166-168]. Henriques and Madeira [35] developed and applied a pattern-based
biclustering algorithm to discover coherent modules from PPI and showed that most
modules were significantly enriched with particular biological functions. Lakizadeh et
al. integrated time series expression data and static PPI networks to extract dynamic PPI
subnetwork and then detected protein complex based on these subnetworks. They
concluded that this method could model the dynamicity inherent in static PPI networks.
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Table 7. Case studies of Biological networks elucidation.
Inputs

Methods

Tools/Databases

Outputs

Refs

Yeast transcriptional network
Nearly 1,000
Saccharomyces cerevisiae
expression profiles; 110 TF
binding location profiles; 30
growth profiles; 1,031
protein interaction; 4,177
complex interactions and
1,175 known interactions
from MIPS

•

Modeling genomic
information as weighted graph

•

Biclustering

•

Generate module graph and
explore associations between
modules

SAMBA

665
significant
modules;
Global Yeast
molecular
network

[150]

Methanogenesis regulatory network
Microarray (1,661
Methanogen genes under 58
conditions);
Upstream regions of all
genes;

• Biclustering to Identify coregulated gene subsets;

cMonkey

• Construct GRN to infer
transcriptional influences of
each bicluster;

Inferelator

Operon prediction from
MicrobesOnline;

• Visualize GRN;

Protein interactions from
String

• Use TF knockout experiment
and extra data and to validate
the GRN model

Cytoscape
Gaggle
-

166
biclusters;
GRN model
including a set
of 1,227 EF
and TF
regulatory
influences that
inter-link the
regulation of
1,661 genes

[163]

Mycobacterium tuberculosis regulatory network
Microarray data
(Mycobacterium
tuberculosis genes under
2,325 conditions);
Upstream regions of all
genes;
~5000 Operon prediction
from MicrobesOnline;
~250,000 protein
interactions from String

• Biclustering to identify coregulated gene subsets;

cMonkey

• Construct GRN model to infer
transcriptional influences of
each bicluster;

Inferelator

• Validate the GRN model using
new datasets; Visualize
Network.

BioTapestry

598
biclusters;
A global
regulatory
network
covering 98%
of MTB genes

[164]

Phaeodactylum tricornutum regulatory network
RNA-Seq (1,214
Phaeodactylum tricornutum
genes from 179 samples);
Genome annotation,
Chloroplastic and
mitochondrial genomic
information, functional
annotation, Protein-protein
interactions

•

Biclustering to identify
putatively co-regulated genes;

cMonkey2

•

Construct regulatory network
to infer regulatory influences;

Inferelator

•

GO enrichment analysis to
identify potential biological
processes carried out by the
co-regulated genes

-

121 biclusters
covering
1,214
metabolic
genes and TFs

[165]
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Biological network decomposition
Two Gene interaction
networks for yeast; Two
PPIs from E. coli and
human

• Biclustering

BicNET

• Assess biological significance
of retrieved modules

GOrilla

modules with
heightened
biological
significance

[35]

4.2 Advanced Application of Biclustering in Biomedical Science
A genetic variation that contributes to a specific disease is usually detected
through single-nucleotide polymorphisms (SNPs), insertion/deletions, variable number
tandem repeats and copy number variants [169]. Besides, understanding the association
between above genomic information and specific diseases has led to the discovery of new
drugs [170].However, the association studies are considered as complicated processes
because disease risks are attributed to the combined effect of both multiple genetic
variants and environmental factors. With the increasing application and decreasing cost
of big data generation techniques in biomedical and health-care informatics, large
volumes of biological and clinical data sets have become available in the public domain.
On one hand, this advance provides materials to identify new therapeutic targets, drug
indications and drug-response biomarkers; on the other hand, it also introduces more
challenges to the data mining approaches [170]. As the applications of biclustering in
basic biological science lead to many discoveries and novel methodologies, there is a
rapidly growing interest in extrapolating it into the big biomedical data. Biclustering is
deemed as a powerful tool that could identify novel target genes, indicated drugs or
biomarkers of drug responses, in which the principles of biclustering being used in
functional annotation and modularity analysis of biological data are also applicable. In
this section, we provide comprehensive guidance and discuss the applications of
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biclustering, particularly the integration with other methods, for detecting disease
subtype, identifying biomarker and gene signatures of disease and gene–drug association.
4.2.1 Disease Subtype Identification
Disease subtype could provide a framework for the development of more accurate
biomarkers by stratification of patient populations [171]. It can be defined by related
molecular characteristics or clinical features [172]. Gene expression data, depicted as a
matrix with genes as columns, and subjects as rows (with known or unknown disease
types), were widely used in molecular subtyping studies. This formulation is reasonable
because pathways responding to specific disease subtypes may be activated across most
the patients of the subtype, and the gene expression can be considered candidate
signatures for subtypes [49]. With benchmark gene expression data sets and wellannotated disease subtype information, biclustering can discriminate biclusters from the
gene expression matrix, containing genes that share similar expression patterns only in
one or some specific subtypes [31, 173]. Hence, denovo identification of biclusters can be
used to group subjects (patients) into disease subtypes, and these identified patient groups
can be further evaluated by linking known clinical characteristics [63]. The evaluation
process assumes that patients from different subtypes tend to have distinctive clinical
features. In cancer subtyping study, survival time, neoplasm disease stage, tumor size,
tumor grade, tumor nuclei percentage and patient age have been commonly used to assess
the subtyping results [33, 117, 118]. Table 8 summed up those application studies in
certain diseases, including leukemia, gastric cancer, breast cancer, lung cancer, etc.
For each characteristic, a dependence test, e.g., Chi-square test, is used to examine
the difference among all subtypes [174, 175]. To be specific, given a clinical characteristic
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(e.g., the presence of an adverse drug reaction), the null hypothesis of the test is that
subtypes of a disease and the characteristic are independent, i.e., there are no differences
among the subtypes regarding that characteristic. After summarizing the frequencies or
counts of cases under different subtypes into a 𝑟 ×

contingency table ( 𝑟 =

𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑜𝑤𝑠, = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑙𝑢𝑚𝑛𝑠), the Chi-square test statistic is calculated by
using the formula:
𝜒2 = ∑

(𝑂 − 𝐸)2
𝐸

where 𝑂 represents the observed frequency, 𝐸 represents the expected frequency
under the null hypothesis, which is computed by:
𝐸=

𝑟𝑜𝑤 𝑡𝑜𝑡𝑎𝑙 × 𝑜𝑙𝑢𝑚𝑛 𝑡𝑜𝑡𝑎𝑙
𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒

The test statistics will be compared to the critical value of 𝜒𝛼 2 ( 𝑑𝑓 = (𝑟 −
1) × ( − 1)). If 𝜒 2 > 𝜒𝛼 2 , the null hypothesis will be rejected, meaning that there are
differences among subtypes regarding that characteristic (see details in Example S1).
Meanwhile, interpretation of the identified biclusters in gene dimension can be carried out,
more details of biomarker and gene signatures detection can be found in the next section.
Table 8. Case studies of disease subtype identification.
Data

Methods

Tools/Databases

Outcomes

Refs

QUBIC

Biclusters with
cancer subtyping
information

[31]

Leukemia
Microarray data with
12,533 probes from 72
patients of different
subtypes of leukemia

• Biclustering by qualitative
biclustering algorithm
Gastric cancer
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• Biclustering on gene
expression data for bicluster
identification;
Microarray data for 80
paired gastric cancer and
reference tissues from
non-treated patients

QUBIC [31];

DAVID [177]
• Pathway enrichment analysis.

KOBAS [178]

Pathways
associated with
cancer
development;

[176]

identified gastric
cancer subtypes

HPID [179]
Breast cancer

Microarray data with
7756 genes and matched
clinical data for 437
primary breast tumor
patients

• Adjust for cohort-correlated
batch effect across the nonadjuvant treated tumor data
set;

ComBat [180]

• Biclustering to identify
molecular-based tumor
subgroup;

cMonkey [52]

• Determine molecular
classifiers for each bicluster;
Microarray data with
17,814 genes across 547
samples
and gene network
consisted of 11,648
genes and 211,794
interactions

• Assign weights to genes
based on impact in the
network and expression
variation;

Similar clinical
features
associated with
tumor within the
same cluster

[181]

Cancer subtypes

[63]

PAM [182]

PageRank [183]

• Weighted biclustering
algorithm based on a seminonnegative matrix trifactorization.

NCIS [63]

Colon and lung cancers
290 colon cancer
samples, each has 384
methylation probes
covering 151 cancerspecific differentially
methylated region
(cDMRs);

• Heterogeneous sparse singular
value decomposition
(HSSVD) based Biclustering

Expression levels of
12,625 genes in 56
patients having lung
cancer

-

Variance
biclusters of
methylation data
in cancer versus
normal patients
using colon
cancer data;

[173]

cancer subtype
patterns using
lung cancer data

4.2.2 Biomarker and Gene Signatures Detection
Biclustering proved to be influential for mining information from elaborate
biomedical data sets, especially in cancer research. Cancer is complicated because of the
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heterogeneity of tumor cells and is recognized as a system-level disease [184, 185].
Biclustering has been used with human gene expression data to identify cancer subtype
patterns [31, 63, 173, 181, 186], metabolic pathways highly related to cancer
progression[176], marker genes of a specific cancer type/subtype [8, 155], and clinical
risk factors of cancer [187]. Also, studies of common or rare diseases have used
biclustering of human gene expression data to identify phenotype-genotype associations
[188, 189], dysregulated transcription modules [190], and genetic risk variants [191].
Depending on the available information, various levels of analyses can be conducted as
summarized below.
Basically, given gene expression matrix with rows representing genes and
columns representing patients, biclustering can identify co-expressed gene clusters that
are specific to characteristics of patients, e.g. certain subtypes or disease stages. If genes
included in the identified biclusters have differential expression patterns between
different subtypes, then they can serve as candidate gene signatures or biomarkers for
cancer staging and subtyping [176]. If predefined gene sets are given, and clinical
characteristics/phenotype labels are also available, researchers can carry out gene set
enrichment analysis (GSEA) first to investigate the correlation between gene sets and
clinical characteristics/covariates (e.g. tumor grade, stage, age or hormone status). Based
on these correlations results, a binary association matrix can be derived, with rows
representing gene sets and columns representing pairwise tests for phenotypes, the
element ‘1’ denoting significant association between gene set and pairwise test, and ‘0’
denoting no significant association. Biclusters identified from this association matrix can
represent modules that associated with known clinical covariates [187].
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A matrix of SNPs or phenotypes and the extended matrices from them, including
a matrix of regression coefficients of SNPs associated with traits and matrix of P-values
of SNPs in traits, were subjected to biclustering to recognize the phenotype–genotype
connections [188, 189, 191]. With the developments of RNA-Seq, whole transcriptomic
data are becoming available to characterize and quantify gene expression [192]. The
recent advent of scRNA-Seq technology has enabled researchers to study heterogeneity
between individual cells and define cell type a based solely on its transcriptome [8].
Using biclustering, researchers can not only group cells into subpopulations but also
identify biologically important gene signatures for each class simultaneously [193]. For
example, Zeisel et al. [155] recently classified single cells from the brain through
biclustering, which identified numerous marker genes and highly restricted expression
patterns of transcription factors for cell types. Kiselev et al. [8] developed a stable and
accurate consensus tool, based on such scRNA-Seq data, which can quantify the inherent
heterogeneity of single cells, define the subclonal composition and identify marker genes.
Meanwhile, new biclustering applications are emerging, such as detecting disease marker
genera from gut biome [194]. The gut microbiome is typically tricky to profile and use of
biclustering enhances identification of specific taxonomic signatures that can support the
elucidation of disease risk [194].
These identified biclusters were subjected to downstream analysis of functional
gene annotation [186, 188], gene network inference [188] or phenomic analysis [188,
189, 191]. Most of the gene functional annotations were done through the UCSC Genome
Browser [195]. Gene networks among clustered genes were commonly constructed by the
Ingenuity Pathways Analysis software developed by QIAGEN. Phenomic analysis
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performs pairwise genetic correlation of traits/phenotype against gene sets identified by
biclustering, which is usually done using hypergeometric statistics or paired ttest. Table 9 gives an overview of biomarker/gene signature identification studies, with
the detailed procedures regarding biclustering and accompanied analyses specified in the
column ‘Methods’. It is noteworthy that the application of biclustering in these
biomedical studies is much more complicated compared with those in basic biological
applications, regarding the data sources, data preprocessing methods and downstream
statistical analyses.
Table 9. Case studies of Biomarker and gene signatures detection.
Data

Methods

Tools/Databases

Outcomes

Refs

Modules
associated
with clinical
covariates in
breast cancer

[187]

12 different
miRNA
clusters

[186]

Breast cancer
Association matrix of
1,008 gene expression
microarray profiles of
primary breast tumors

Matrix of normalized
miRNA Sequencing
expression profiles

• Biclustering binary data matrix.

iBBiG

• Biclustering to evaluate miRNA
deregulation;

ISA[100]

• Validate each bicluster by an external
repository of different groups of
miRNAs in human species;
• Compare results with a different
biclustering algorithm.

MetaMirClust
[196]
UCSC [195]
SAMBA [146]

Osteoporosis

Regression coefficients
matrix of 1,109 unique
SNPs associated with
23 studied traits from
the GWAS data of
the Framingham
Osteoporosis Study

• GWAS database mining;

Tagger [197]

• Biclustering on matrix of SNPs against
phenotypes;

Bayesian
biclustering
[198]
UCSC [199]

• Gene annotation and identification of
enriched canonical pathway and gene
network inference.

IPA

SNPphenotype
connections;
Highly
genetically
correlated
traits;
Candidate
genes
identified for

[188]
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multiple bone
traits
Williams-Beuren syndrome
Normalized skin
fibroblast microarray
dataset including 9,329
probe sets and 96
samples

• Identify transcriptional modules;
• Test modules containing at least ten
genes for dysregulation using
hypergeometric distribution.

ISA[100]
-

72
dysregulated
modules were
found

[190]

Causally
cohesive
genotypephenotype
relations

[189]

Genetic risk
variants for
complex
diseases

[191]

Schizophrenia

8,023 subjects, 4,196
patients, and 3,827
controls, with 2,891
SNPs in each subject

• Perform biclustering for both
phenotype and genotype data;

bioNMF [62]

• Cross-correlate phenotype and
genotype biclusters;

-

• Organize and encode relations into
topologically organized networks;
• Estimate genotype associated disease
risk.

PGMRA [189]
SKAT[200]

Complex diseases
SparseBC [201]
p-value matrix of
466423 SNPs in 32
independent
diseases/traits

• Identify biclusters of diseases/traits
and SNPs

LAS [57]
SSVD [202]

• Map detected SNPs to genes

-

4.2.3 Gene-drug Association
In drug development, it is vital to understand the complicated responses in the
human body to various drug treatments [203, 204]. However, rigorous testing of safety
and efficacy of novel drug makes drug development time-consuming, expensive and
often unsuccessful. Alternatively, computational drug repositioning is termed as an
efficient way to identify new applications for current medicines [205]. By the
advancement of biotechnologies, a significant amount of gene expression data becomes a
paramount component in characterizing the human responses to drugs. Here, we review
the applications of biclustering in the context that is considered appropriate in revealing
the co-expression patterns encompassed in the drug-perturbed responses [206]. The
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genome-scale drug-treated gene expression data were served as raw materials for
identification of co-expression modules using biclustering methods, where different drug
treatments were conditions. Table 10 gave an overview of four typical studies that were
examining the drug-induced co-expression modules. In these studies, information for
both gene and drug members was mined to characterize the detected drug-induced
modules. Conservation of identified biclusters was first evaluated across data sets through
overlapping genes and drugs [206]. Then, genes and drugs in the bicluster were
examined, respectively. Functional enrichment of these genes was tested using the
DAVID knowledge base to determine the biological relevance of these biclusters [206,
207]. Enrichment of drug annotation terms can be assessed by various databases, such as
STRING [208] and DAVID [177], for identification of transcriptional factors linked to
these biclusters [206, 209, 210].
Table 10. Case studies of gene-drug association.
Data

Methods

Tools/Databases

Outcomes

Refs

859 comodules were
identified, and
drug-gene
associations
were
predicted
more
accurately
than other
algorithms

[207]

Drug-induced
transcriptional
modules

[206]

Drug-gene associations
• Identify co-modules of drugs and genes;

DrugBank [211]

NCI-60 cancer cell
line in drug
response;
Gene expression
data

PPA [207]

• Test drug-gene association.

Connectivity Map
[212]

Drug-Induced Transcriptional Modules
6,100 gene
expression profiles
of human cancer
cell treated with
1,309 small

• Biclustering drug‐induced gene
expression profiles [100];
• Hypergeometric test for significance
assessment of overlaps among gene
members;

ISA [50]

-
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molecules from
CMap [212];
1,743 expression
profiles from liver
tissues of drugtreated rats [213].

• Predict novel gene functions by
comparing modules of human cancer and
rat liver cell lines;

STRING [208]

• Test enriched gene functions and
identified biological themes among
transcriptional modules.

DAVID [177]

Transcriptional factors (TFs) for drug-associated gene modules
7,056 genome-wide
expression profiles
of five different
human cell lines
treated with 1,309
chemical agents at
different dosages
from CMap [212]

• Identify drug-gene modules by
biclustering method;
• Indicate Gene Ontology (GO) and Kyoto
Encyclopedia of Genes and Genomes
(KEGG) information associated with
genes in modules;
• Use cumulative hypergeometric test to
evaluate drug target enrichment.

FABIA [32]

DAVID [110]

Links
between 28
modules with
12 TFs were
detected

[209]

-

Transcriptomics and decision in early-stage of pharmaceutical drug discovery
Transcriptomic
profiles in eight
drug discovery
projects of
oncology, virology,
neuroscience and
metabolic diseases.

• Normalize and filtrate mRNA expression
data;

-

• Identify transcriptional modules;

FABIA [32]

• Identify transcriptional modules related
to the desired effect using target-related
bioassay measurements.

PSVM [214]

Transcription
al effects of
compounds

[210]

4.3 Summary
GBA is the basis of expression profile-based biclustering; however, co-expression
does not guarantee co-regulation. One popular strategy to further elucidate co-regulation
is to integrate supporting data that provide evidence of co-regulation with expression
data, e.g. motif prediction and network connection. In support of a more comprehensive
clarification of complex biological systems in a cell, existing biological network
inference tools should embed multiple regulatory signals, e.g. TF, lncRNAs and
miRNAs, and organically integrate biclustering within their network construction
framework. Use of these methods and integration of well-annotated phenotypic data can
enhance the identification of CEM and improve systems-level insights. Combination of
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biclustering of gene expression and clinical phenotype data with successive enrichment
analyses has revealed disease subtype patterns and diseases biomarkers. Biclustering has
contributed to drug development by exposing the co-expression patterns from the drugtreated gene expression data. Most uses of biclustering in biomedicine to date rely on a
handful of conventional biclustering algorithms, as it remains unclear which are
sufficiently accurate for any given data type.
A workflow of biclustering application is proposed here to integrate the methods
and tools used in both biological and biomedical fields discussed above. As shown
in Figure 16, there are three layers (Data, Methods and Results) in this workflow. The
data sources in the first layer provide the information directly collected and derived from
genotyping and phenotyping results. Different method combinations in layer two can be
used for various analytical requirements. Biclustering can be used to analyze phenotype
matrix, genotype matrix, as well as the derived association matrix of these two matrices.
A few example tools were shown in the figure for biclustering methods. These
biclustering methods are often accompanied by downstream analysis, such as functional
annotation, module analysis or network construction, to interpret the identified biclusters,
together with statistical evaluation tools applied to demonstrate bicluster associations.
Examples of results from a combination of the methods identified in layer two provide
specific illustrations of corresponding outputs results [31, 181, 215-217]. The
connections between data and methods offer model analysis paths for researchers to use
depending on the characteristics of their data.
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Figure 16. The overall workflow of biclustering application mechanism related to upstream and
downstream process. Three layers are shown to provide the path from raw data, appropriate
analytical methods/tools to various cases of the result. The power of biclustering is illustrated by
the ability to generate co-expressed gene modules, subtype or biomarker, regulatory networks,
clinical entities and estimated disease-free survival (DFS) distribution.

The identified workflow guides many current studies; however, new
biotechnologies are developing and emerging rapidly, while the corresponding
biclustering tools are not evolving at a parallel pace. This situation is an important factor
limiting the application of biclustering analysis to more complex data sets, e.g.
multidimensional biological image data, requiring integration of multiple variables.
Meanwhile, considering the variety and complexity of data from various platforms, the
data integration and analyses are not trivial, and it is more challenge to combine multiple
required computational techniques with biclustering analysis. Furthermore, different data
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types may need specifically designed biclustering algorithms. For example, scRNA-Seq
data exhibit higher heterogeneity than RNA-Seq data and are increasing in popularity;
however, few biclustering algorithms are explicitly designed for these new data. Hence,
additional biclustering methods, which include specific design attributes taking the
characteristics of biological and biomedical data into account, are still needed to facilitate
larger-scale applications of biclustering.
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APPENDIX 2: Data Links
The link for all the datasets used in the thesis is provided in Table11.
Table 11. Data links
Data

Link

E. coli RNA-Seq

http://bmbl.sdstate.edu/downloadFiles/E.coli%20RNA-seq/

Simulation data

http://bmbl.sdstate.edu/downloadFiles/simulation/

TCGA data

https://zenodo.org/record/1157938#.W489C_ZFwiQ

scRNA-Seq data

https://scrnaSeq-public-datasets.s3.amazonaws.com/manualdata/yan/nsmb.2660-S2.csv

GSE52583

http://www.cs.cmu.edu/~jund/scdiff/download/data/treutlein2014

mouse olfactory bulb
scRNA-Seq data

http://www.spatialtranscriptomicsresearch.org/wpcontent/uploads/2016/07/Rep2_MOB_count_matrix-1.tsv

GSE 48968

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48968

GSE60402

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60402

Note
Include expression
matrix and five sets
of pathways
Include expression
matrix and ten
groups of modules
Used in 2.3 and 2.5.

MOB Replicate2
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APPENDIX 3: Citation Map for QUBIC
The citation map for QUBIC (including QUBIC algorithm, Qserver and QUBICR) is provided in Figure 17.

Figure 17. Citation map for QUBIC
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APPENDIX 5: Curriculum Vitae

Juan Xie
605-690-3056 | https://www.linkedin.com/in/juan-xie/ | juanxie.84@gmail.com
EDUCATION
M.S. in Statistics (GPA: 4.0)

August 2016-Sep 2018

South Dakota State University, Brookings, SD
•

Coursework: Statistical Inference, Regression analysis, Time series data analysis,
Next Generation Sequencing Data Analysis, Survival analysis, Predictive analysis

M.S. in Environmental Science
University of Chinese Academy of Sciences, Beijing, China
B.S. in Food Science and Engineering
Hua Zhong Agricultural University, Wuhan, China
EMPLOYMENT
Graduate Research Assistant

Aug 2016--Present

Bioinformatics and Mathematical Biosciences Lab, South Dakota State University
•

Develop biclustering algorithm and tools for large scale gene expression data

•

Analyze NGS data from bacteria and plant

•

Maintain lab’s high-performance computing resource

•

Write local and national level research proposals

PUBLICATIONS
1. Yu Zhang, Juan Xie, Jinyu Yang, et al. QUBIC: a Bioconductor package for
qualitative biclustering analysis of gene co-expression data. Bioinformatics,
btw635,2016.
2. Juan Xie, Anjun Ma, Anne Fennell, Jing Zhao, Qin Ma, 2018, It is time to apply
biclustering: a comprehensive review of biclustering applications in biological
and biomedical data. Briefings in Bioinformatics, DOI:10.1093/bib/bby014
3. Adam McDermaid, Xin Chen, Yiran Zhang, Cankun Wang, Shaopeng Gu, Juan
Xie, Qin Ma. A new machine learning-based framework for mapping uncertainty
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analysis in RNA-Seq read alignment and gene expression estimation. Frontiers in
Genetics. doi: 10.3389/fgene.2018.00313
4. Ying Li, Shi Xiaohu, Liang Yanchun, Juan Xie, Yu Zhang, Qin Ma. RNATVcurve: A Web Server for RNA Secondary Structure Comparison based on a
Multi-Scale Similarity of its Triple Vector Representation. BMC Bioinformatics,
2017, doi: 10.1155/2017/5652041
5. Juan Xie, Anjun Ma, Yu Zhang, Bingqiang Liu, Changlin Wan, Sha Cao, Chi
Zhang, Qin Ma. QUBIC2: A novel biclustering algorithm for large-scale bulk
RNA-sequencing and single-cell RNA-sequencing data analysis. (bioRxiv,
https://www.biorxiv.org/content/early/2018/09/07/409961)
6. Suresh Damodaran, Amélie Dubois, Juan Xie, Qin Ma, Valérie Hindié, Senthil
Subramanian. GmZPR3d interacts with GmHD-ZIP III proteins and regulates
soybean root and nodule vascular development. (Under review in Frontiers in
Plant Science)
PRESENTATIONS
•

Hypothesis-driven and discovery-driven analysis of Grapevine expression data.
January 16, 2018. Plant and Animal Genome Conference, Jan. 14-18, San Diego,
CA, USA. (Oral presentation)

•

Biclustering in Big Biological Data Analysis. 8th Annual Avera SDSU Research
Symposium, Oct 26, 2016, Brookings, SD. (Poster presentation)

•

QUBIC: An R package of qualitative biclustering for gene co-expression analysis.
The 101st Annual Meeting of the South Dakota Academy of Science, April 8-9,
2016, Sioux Falls, SD. (Poster presentation)

SKILLS
•

R programming

•

Bash scripting

•

SAS, C, C++, SPSS experience

•

Next-Generation Sequencing data analysis

